<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Colchicine for pericarditis - Alabed, S - 2014 | Cochrane Library</title> <meta content="Colchicine for pericarditis - Alabed, S - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010652.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Colchicine for pericarditis - Alabed, S - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010652.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010652.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Colchicine for pericarditis" name="citation_title"/> <meta content="Samer Alabed" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="samer.alabed@conted.ox.ac.uk" name="citation_author_email"/> <meta content="Juan B Cabello" name="citation_author"/> <meta content="Hospital General Universitario de Alicante" name="citation_author_institution"/> <meta content="Greg J Irving" name="citation_author"/> <meta content="University of Liverpool" name="citation_author_institution"/> <meta content="Mohammed Qintar" name="citation_author"/> <meta content="Cleveland Clinic Foundation" name="citation_author_institution"/> <meta content="Amanda Burls" name="citation_author"/> <meta content="City University London" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD010652.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/08/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010652.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010652.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010652.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Disease; Anti‐Inflammatory Agents, Non‐Steroidal [adverse effects, *therapeutic use]; Aspirin [therapeutic use]; Colchicine [adverse effects, *therapeutic use]; Ibuprofen [therapeutic use]; Indomethacin [therapeutic use]; Pericarditis [*drug therapy]; Randomized Controlled Trials as Topic; Recurrence" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010652.pub2&amp;doi=10.1002/14651858.CD010652.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="UiM8QuvV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010652\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010652\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010652.pub2",title:"Colchicine for pericarditis",firstPublishedDate:"Aug 28, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UiM8QuvV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010652.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010652.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010652.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010652.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010652.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010652.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010652.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010652.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010652.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010652.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>16019 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010652.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-sec-0105"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-sec-0032"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-sec-0033"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-sec-0068"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-sec-0099"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/appendices#CD010652-sec-0110"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/table_n/CD010652StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/table_n/CD010652StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Colchicine for pericarditis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/information#CD010652-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Samer Alabed</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/information#CD010652-cr-0003">Juan B Cabello</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/information#CD010652-cr-0004">Greg J Irving</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/information#CD010652-cr-0005">Mohammed Qintar</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010652.pub2/information#CD010652-cr-0006">Amanda Burls</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/information/en#CD010652-sec-0113">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 August 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010652.pub2">https://doi.org/10.1002/14651858.CD010652.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010652-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010652-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010652-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010652-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010652-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010652-abs-0001" lang="en"> <section id="CD010652-sec-0001"> <h3 class="title" id="CD010652-sec-0001">Background</h3> <p>Pericarditis is the inflammation of the pericardium, the membranous sac surrounding the heart. Recurrent pericarditis is the most common complication of acute pericarditis, causing severe and disabling chest pains. Recurrent pericarditis affects one in three patients with acute pericarditis within the first 18 months. Colchicine has been suggested to be beneficial in preventing recurrent pericarditis. </p> </section> <section id="CD010652-sec-0002"> <h3 class="title" id="CD010652-sec-0002">Objectives</h3> <p>To review all randomised controlled trials (RCTs) that assess the effects of colchicine alone or combined, compared to any other intervention to prevent further recurrences of pericarditis, in people with acute or recurrent pericarditis. </p> </section> <section id="CD010652-sec-0003"> <h3 class="title" id="CD010652-sec-0003">Search methods</h3> <p>We searched the following bibliographic databases on 4 August 2014: Cochrane Central Register of Controlled Trials (CENTRAL, Issue 7 of 12, 2014 on <i>The Cochrane Library</i>), MEDLINE (OVID, 1946 to July week 4, 2014), EMBASE (OVID, 1947 to 2014 week 31), and the Conference Proceedings Citation Index ‐ Science on Web of Science (Thomson Reuters) 1990 to 1 Aug 2014. We did not apply any language or time restrictions. </p> </section> <section id="CD010652-sec-0004"> <h3 class="title" id="CD010652-sec-0004">Selection criteria</h3> <p>RCTs of people with acute or recurrent pericarditis who are receiving colchicine compared to any other treatment, in order to prevent recurrences. </p> </section> <section id="CD010652-sec-0005"> <h3 class="title" id="CD010652-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected trials for inclusion, extracted data and assessed the risk of bias. The first primary outcome was the time to recurrence, measured by calculating the hazard ratios (HRs). The second primary outcome was the adverse effects of colchicine. Secondary outcomes were the rate of recurrences at 6, 12 and 18 months, and symptom relief. </p> </section> <section id="CD010652-sec-0006"> <h3 class="title" id="CD010652-sec-0006">Main results</h3> <p>We included four RCTs, involving 564 participants in this review. We compared the effects of colchicine in addition to a non‐steroidal anti‐inflammatory drug (NSAID) such as ibuprofen, aspirin or indomethacin to the effects of the NSAID alone. Two comparable trials studied the effects of colchicine in 204 participants with recurrent pericarditis and two trials studied 360 people with acute pericarditis. All trials had a moderate quality for the primary outcomes. We identified two on‐going trials; one of these trials examines acute pericarditis and the other assesses recurrent pericarditis. </p> <p>There was moderate quality evidence that colchicine reduces episodes of pericarditis in people with recurrent pericarditis over 18 months follow‐up (HR 0.37; 95% confidence interval (CI) 0.24 to 0.58). It is expected that at 18 months, the number needed to treat (NNT) is 4. In people with acute pericarditis, there was moderate quality evidence that colchicine reduces recurrence (HR 0.40; 95% CI 0.27 to 0.61) at 18 months follow‐up. Colchicine led to a greater chance of symptom relief at 72 hours (risk ratio (RR) 1.4; 95% CI 1.26 to 1.56; low quality evidence). Adverse effects were mainly gastrointestinal and included abdominal pain and diarrhoea. The pooled RR for adverse events was 1.26 (95% CI 0.75 to 2.12). While the number of people experiencing adverse effects was higher in the colchicine than the control groups (9% versus 7%), the quality of evidence was low owing to imprecision, and there was no statistically significant difference between the treatment groups (P = 0.42). There was moderate quality evidence that treatment with colchicine led to more people stopping treatment due to adverse events (RR 1.87; 95% CI 1.02 to 3.41). </p> </section> <section id="CD010652-sec-0007"> <h3 class="title" id="CD010652-sec-0007">Authors' conclusions</h3> <p>Colchicine, as adjunctive therapy to NSAIDs, is effective in reducing the number of pericarditis recurrences in patients with recurrent pericarditis or acute pericarditis. However, evidence is based on a limited number of small trials. Patients with multiple resistant recurrences were not represented in any published or on‐going trials, and it is these patients that are in the most need for treatment. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010652-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010652-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010652-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010652-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010652-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010652-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010652-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010652-abs-0004" lang="en"> <h3>Systematic review of randomised controlled trials about the efficacy and safety of colchicine in people with pericarditis </h3> <p>Pericarditis is the inflammation and swelling of the tissue covering the outer layer of the heart. Pericarditis causes severe and disabling chest pain and fever, however the main issue is the repeated recurrence of pericarditis attacks. Colchicine is an ancient medication that has been used in the treatment of other inflammatory diseases such as gout. </p> <p>We wanted to discover whether colchicine alone or added to other medications is better or worse than alternative therapies in preventing pericarditis. We have reviewed all randomised controlled trials about the effect of colchicine in preventing recurrence of pericarditis in people with pericarditis. We found four trials involving 564 participants, who were followed up for at least 18 months. Two studies examined the use of colchicine in people with recurrent pericarditis and two examined the use of colchicine in people with a first episode of pericarditis. The evidence is current to August 2014. </p> <p>The trials showed that people taking colchicine have a lower risk of developing pericarditis recurrence and a higher proportion experience symptom relief. It is expected that at 18 months, one pericarditis recurrence can be avoided for every four people receiving colchicine with NSAIDs rather than NSAIDs alone. Adverse effects were reported in all trials and affected 15 people (9%) of the 162 taking colchicine. Adverse effects included abdominal pain, nausea and vomiting. </p> <p>Two studies were designed so that participants knew the type of intervention they were taking and people in the comparison group had no dummy pill. The results of these studies could exaggerate the effects of the drug. </p> <p>The evidence suggests beneficial effects of colchicine in preventing recurrence of pericarditis, however this is based on a limited number of small trials. More trials are currently being done and we await their results to see if the benefits of colchicine can be further confirmed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010652-sec-0105" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010652-sec-0105"></div> <h3 class="title" id="CD010652-sec-0106">Implications for practice</h3> <section id="CD010652-sec-0106"> <p>Colchicine as adjunctive therapy to NSAIDs is effective in reducing the number of further recurrences in patients with recurrent pericarditis or acute pericarditis. However, data is limited and may not be sufficient to recommend routine use of colchicine for the general pericarditis population. It has also been found that patients with multiple resistant recurrences have not been represented in any trials, and it is these patients that are in most need of a treatment. </p> <p>No severe adverse effects were reported and all adverse effects were related to gastrointestinal sensitivity such as abdominal pain, diarrhoea and nausea or vomiting. Although we do not have definitive evidence that colchicine increases the risk of adverse events overall, it was associated with higher therapy withdrawal rates than the control group. </p> </section> <h3 class="title" id="CD010652-sec-0107">Implications for research</h3> <section id="CD010652-sec-0107"> <p>Pericarditis is a relatively common disease which can relapse and recur despite treatment. This can cause frustration for both patients and healthcare providers. Current research of the use of colchicine includes two RCTs in people with acute pericarditis and two in people with recurrent pericarditis. Another two on‐going RCTs are awaited. </p> <p>New research should study participants not covered in the current trials, such as people with multiple resistant pericarditis recurrences, elderly people and children. About 2 to 3 in 1000 hospitalised children experience episodes of pericarditis (<a href="./references#CD010652-bbs2-0019" title="YazigiA , Abou‐CharafLC . Colchicine for recurrent pericarditis in children. Acta Paediatrica1998;87(5):603‐4. [PUBMED: 9641750] ">Yazigi 1998</a>). It is therefore important to assess the efficacy and safety of colchicine in paediatric populations. In addition, trials looking at different populations such as from a non‐European background are necessary. Other questions that need to be addressed are the optimal therapy durations, loading and maintenance doses. </p> <p>All existing trials of colchicine in pericarditis have been conducted by similar research groups. Although this is not a risk of bias itself, it is beneficial to have trials undertaken by different researchers. </p> <p>We know of one ongoing RCTs ( <a href="./references#CD010652-bbs2-0021" title="EUCTR2009‐011258‐16‐ES . The efficacy of colchicine administration in the first sign of pericarditis to avoid recurrences [Eficacia de la colchicina administrada en el primer brote de pericarditis para evitar la aparición de recidivas]. http://apps.who.int/trialsearch/trial.aspx?trialid=EUCTR2009‐011258‐16‐ES (accessed 20 March 2014). ">EUCTR2009‐011258‐16‐ES</a>) registered on ClinicalTrials.gov and the EU Clinical Trials Register seeking to address the use of colchicine in pericarditis. We hope that with the results of the ongoing research, a more definite conclusion can be given. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010652-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010652-sec-0022"></div> <div class="table" id="CD010652-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Time to recurrence of pericarditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Time to recurrence of pericarditis</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recurrent pericarditis</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Intervention: colchicine with NSAID; Comparison: NSAID alone<br/> Follow‐up: median 18 months<br/> Setting: multicentre secondary care </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.37</b> <br/> (0.24 to 0.58) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Acute pericarditis</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers) </p> <p>Intervention: colchicine with NSAID; Comparison: NSAID alone</p> <p>Follow‐up: median 18 months<br/> Setting: multicentre secondary care </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.40</b> <br/> (0.27 to 0.61) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>360<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>ECG</b> : electrocardiography; <b>HR:</b> Hazard ratio; <b>NSAID</b>: non‐steroidal anti‐inflammatory drug </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> High risk of bias in blinding domain. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010652-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Adverse effects of colchicine</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Adverse effects of colchicine for pericarditis</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Colchicine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Total adverse effects</b> <br/> Patient reported<br/> Follow‐up: median 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.26</b> <br/> (0.75 to 2.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>564<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕</p> <p><b>low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>103 per 1000</b> <br/> (61 to 173) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>69 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>87 per 1000</b> <br/> (52 to 146) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse effects necessitating stop of therapy</b> <br/> Patient reported<br/> Follow‐up: median 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.87</b> <br/> (1.02 to 3.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>564<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>93 per 1000</b> <br/> (51 to 169) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>62 per 1000</b> <br/> (34 to 113) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> P value &gt; 0.05 (imprecise).<br/> <sup>2</sup> High risk of bias in blinding domain. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010652-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Recurrences in patients with recurrent pericarditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Recurrences in patients with recurrent pericarditis</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Colchicine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>6 months</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Follow‐up: mean 6 months </p> <p>Intervention: colchicine with NSAID<br/> Comparison: NSAID alone<br/> Setting: multicentre secondary care </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.28</b> <br/> (0.17 to 0.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>204<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>1,2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>490 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>137 per 1000</b> <br/> (83 to 230) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>481 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>135 per 1000</b> <br/> (82 to 226) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>12 months</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Follow‐up: median 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.36</b> <br/> (0.23 to 0.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>204<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>1,2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>520 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>187 per 1000</b> <br/> (120 to 291) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>510 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>184 per 1000</b> <br/> (117 to 286) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>18 months</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Follow‐up: median 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.38</b> <br/> (0.25 to 0.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>204<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>1,2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>539 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>205 per 1000</b> <br/> (135 to 313) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>533 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>203 per 1000</b> <br/> (133 to 309) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> High risk of bias in blinding domain.<br/> <sup>2</sup> Low precision (small sample size and small number of events). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010652-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Recurrence rate in patients with acute pericarditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Recurrence rate in patients with acute pericarditis</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Colchcine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>6 months</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Follow‐up: mean 6 months<br/> Intervention: colchicine with NSAID </p> <p>Comparison: NSAID alone<br/> Setting: multicentre secondary care </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.36</b> <br/> (0.23 to 0.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>360<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>306 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>110 per 1000</b> <br/> (70 to 177) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>292 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>105 per 1000</b> <br/> (67 to 169) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>12 months</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Follow‐up: median 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.4</b> <br/> (0.26 to 0.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>360<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>333 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>133 per 1000</b> <br/> (87 to 203) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>321 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>128 per 1000</b> <br/> (83 to 196) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>18 months</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Follow‐up: median 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.41</b> <br/> (0.28 to 0.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>360<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>367 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000</b> <br/> (103 to 224) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>358 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>147 per 1000</b> <br/> (100 to 218) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> High risk of bias in blinding domain. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010652-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Symptom relief for pericarditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Symptom relief for pericarditis</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Colchcine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Symptom relief at 72 hours</b> <br/> Patient reported<br/> Follow‐up: median 7 days<br/> Intervention: colchicine with NSAID </p> <p>Comparison: NSAID alone<br/> Setting: multi centre secondary care </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.40</b> <br/> (1.26 to 1.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>564<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕<br/> <b>low</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>592 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>829 per 1000</b> <br/> (746 to 924) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>617 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>864 per 1000</b> <br/> (777 to 963) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Two open‐label studies.<br/> <sup>2</sup> High risk of bias in selective reporting domain. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010652-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010652-sec-0023"></div> <section id="CD010652-sec-0024"> <h3 class="title" id="CD010652-sec-0024">Description of the condition</h3> <section id="CD010652-sec-0025"> <h4 class="title">Definitions</h4> <p>Pericarditis is the inflammation of the pericardium, the membranous sac surrounding the heart. Acute pericarditis is idiopathic without an obvious aetiology in 80% to 90% of cases but has a presumed viral origin (<a href="./references#CD010652-bbs2-0033" title="DudzinskiDM , MakGS , HungJW . Pericardial diseases. Current Problems in Cardiology2012;37(3):75‐118. ">Dudzinski 2012</a>). Other causes include tuberculosis, or bacterial and neoplastic diseases that are more common in low‐income countries (<a href="./references#CD010652-bbs2-0070" title="ZayasR , AnguitaM , TorresF , GiménezD , BergillosF , RuizM , et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. American Journal of Cardiology1995;75(5‐6):378‐82. ">Zayas 1995</a>). </p> <p>Recurrent pericarditis is both the most common and most troublesome complication of acute pericarditis and is mostly idiopathic. This is because the exact cause of the recurrence of pericarditis is not known, but appears to be autoimmune as indicated by the presence of autoantibodies and response to steroids (<a href="./references#CD010652-bbs2-0030" title="CantariniL , ImazioM , BriziMG , LucheriniOM , BrucatoA , CimazR , et al. Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clinical Reviews in Allergy and Immunology2013;44(1):6‐13. ">Cantarini 2013</a>). There are two types of recurrent pericarditis, intermittent or incessant. In the incessant type, discontinuation of NSAIDs usually causes a relapse in less than six weeks. In the intermittent type, people have varying symptom‐free intervals, usually longer than six weeks, without therapy (<a href="./references#CD010652-bbs2-0064" title="Soler‐SolerJ , Sagrista‐SauledaJ , Permanyer‐MiraldaG . Relapsing pericarditis. Heart2004;90(11):1364‐8. ">Soler‐Soler 2004</a>). </p> </section> <section id="CD010652-sec-0026"> <h4 class="title">Incidence</h4> <p>The actual incidence of acute pericarditis in unknown, but it is estimated to be 28 cases per 100,000 population/year (<a href="./references#CD010652-bbs2-0045" title="ImazioM , CecchiE , DemichelisB , ChinagliaA , IernaS , DemarieD , et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart2008;94(4):498‐501. ">Imazio 2008a</a>). It is responsible for 4% of all causes of chest pain (<a href="./references#CD010652-bbs2-0050" title="LaunbjergJ , FruergaardP , HesseB , JørgensenF , ElsborgL , PetriA . Long‐term risk of death, cardiac events and recurrent chest pain in patients with acute chest pain of different origin. Cardiology1996;87(1):60‐6. ">Launbjerg 1996</a>) and 0.1% of all hospitalisations (<a href="./references#CD010652-bbs2-0056" title="PölzlG , Lorsbach‐KöhlerA , Mussner‐SeeberC , GunschlM , FrickM . Medical treatment for pericarditis ‐ the role of colchicine [Medikamentöse therapie der perikarditis ‐ bedeutung von colchicin]. Austrian Journal of Cardiology2011;18(1‐2):30‐40. ">Pölzl 2011</a>). Recurrent pericarditis can occur in up to 20% to 30% of people who have experienced acute pericarditis (<a href="./references#CD010652-bbs2-0036" title="FowlerNO . Recurrent pericarditis. Cardiology Clinics1990;8(4):621‐6. ">Fowler 1990</a>; <a href="./references#CD010652-bbs2-0006" title="AdlerY , FinkelsteinY , GuindoJ , Rodriguez de la SernaA , ShoenfeldY , Bayes‐GenisA , et al. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation1998;97(21):2183‐5. [PUBMED: 9626180] ">Adler 1998</a>); this figure increases to 50% after the first recurrence (<a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>). The rate of recurrence varies and can be a single episode in some people, however, other people can experience more frequent episodes over many years. Almost 45% of people experience two episodes, 40% have between three and five episodes, and 10% have more than five episodes (<a href="./references#CD010652-bbs2-0064" title="Soler‐SolerJ , Sagrista‐SauledaJ , Permanyer‐MiraldaG . Relapsing pericarditis. Heart2004;90(11):1364‐8. ">Soler‐Soler 2004</a>; <a href="./references#CD010652-bbs2-0063" title="ShabetaiR . Recurrent pericarditis. Circulation2005;112(13):1921‐3. ">Shabetai 2005</a>). </p> </section> <section id="CD010652-sec-0027"> <h4 class="title">Presentation and diagnosis</h4> <p>The manifestation of acute pericarditis is a pleuritic chest pain with a sign or symptom marking the activity of the disease, such as fever, a pericardial rub, electrocardiography (ECG) changes (a widespread ST‐segment elevation or PR‐segment depression), pericardial effusion and raised inflammatory markers (erythrocyte sedimentation rate or C‐reactive protein (CRP)) (<a href="./references#CD010652-bbs2-0065" title="SpodickDH . Acute pericarditis. JAMA2003;289(9):1150‐3. ">Spodick 2003</a>; <a href="./references#CD010652-bbs2-0069" title="TroughtonRW , AsherCR , KleinAL . Pericarditis. Lancet2004;363(9410):717‐27. ">Troughton 2004</a>). Acute pericarditis is diagnosed if at least two of these manifestations are met (<a href="./references#CD010652-bbs2-0033" title="DudzinskiDM , MakGS , HungJW . Pericardial diseases. Current Problems in Cardiology2012;37(3):75‐118. ">Dudzinski 2012</a>). </p> <p>Recurrent pericarditis is a repeat episode of acute pericarditis and can have similar symptoms, although it tends to be milder (<a href="./references#CD010652-bbs2-0064" title="Soler‐SolerJ , Sagrista‐SauledaJ , Permanyer‐MiraldaG . Relapsing pericarditis. Heart2004;90(11):1364‐8. ">Soler‐Soler 2004</a>; <a href="./references#CD010652-bbs2-0023" title="AdlerY , ImazioM . Recurrent pericarditis. www.uptodate.com/home (accessed 2 July 2013). ">Adler 2011</a>). There are no uniform diagnostic criteria for recurrent pericarditis (<a href="./references#CD010652-bbs2-0043" title="ImazioM , BrucatoA , AdlerY , BrambillaG , ArtomG , CecchiE , et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. American Journal of Cardiology2007;100(6):1026‐8. ">Imazio 2007</a>), however, observational studies identified pleuritic chest pain, increased CRP and ECG changes as the minimum criteria for diagnosing a recurrent episode of acute pericarditis (<a href="./references#CD010652-bbs2-0028" title="BrucatoA , BrambillaG , MoreoA , AlbertiA , MunfortiC , GhirardelloA , et al. Long‐term outcomes in difficult‐to‐treat patients with recurrent pericarditis. American Journal of Cardiology2006;98(2):267‐71. ">Brucato 2006a</a>; <a href="./references#CD010652-bbs2-0049" title="KhandakerMH , EspinosaRE , NishimuraRA , SinakLJ , HayesSN , MelduniRM , et al. Pericardial disease: diagnosis and management. Mayo Clinic Proceedings2010;85(6):572‐93. ">Khandaker 2010</a>). </p> </section> <section id="CD010652-sec-0028"> <h4 class="title">Prognosis</h4> <p>The first relapse usually occurs within 18 months after the initial pericarditis episode (<a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>; <a href="./references#CD010652-bbs2-0014" title="ImazioM , DemichelisB , ParriniI , CecchiE , DemarieD , GhisioA , et al. Management, risk factors, and outcomes in recurrent pericarditis. The American Journal of Cardiology2005;96(5):736‐9. [PUBMED: 16125506] ">Imazio 2005b</a>). However, people can have many relapses that manifest as severe chest pain lasting from several hours to several days. These painful and disabling episodes impair quality of life and cause a severe clinical problem (<a href="./references#CD010652-bbs2-0064" title="Soler‐SolerJ , Sagrista‐SauledaJ , Permanyer‐MiraldaG . Relapsing pericarditis. Heart2004;90(11):1364‐8. ">Soler‐Soler 2004</a>). </p> <p>Acute and recurrent pericarditis can be complicated by life‐threatening consequences, such as pericardial effusion, tamponade or constriction, which may increase mortality (<a href="./references#CD010652-bbs2-0064" title="Soler‐SolerJ , Sagrista‐SauledaJ , Permanyer‐MiraldaG . Relapsing pericarditis. Heart2004;90(11):1364‐8. ">Soler‐Soler 2004</a>; <a href="./references#CD010652-bbs2-0033" title="DudzinskiDM , MakGS , HungJW . Pericardial diseases. Current Problems in Cardiology2012;37(3):75‐118. ">Dudzinski 2012</a>). These complications can occur in up to 3.5% of people in recurrent pericarditis and even more frequently in people with acute pericarditis (<a href="./references#CD010652-bbs2-0043" title="ImazioM , BrucatoA , AdlerY , BrambillaG , ArtomG , CecchiE , et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. American Journal of Cardiology2007;100(6):1026‐8. ">Imazio 2007</a>). However, in the long term, complications are rare and the prognosis of recurrent pericarditis is good (<a href="./references#CD010652-bbs2-0028" title="BrucatoA , BrambillaG , MoreoA , AlbertiA , MunfortiC , GhirardelloA , et al. Long‐term outcomes in difficult‐to‐treat patients with recurrent pericarditis. American Journal of Cardiology2006;98(2):267‐71. ">Brucato 2006a</a>). </p> </section> </section> <section id="CD010652-sec-0029"> <h3 class="title" id="CD010652-sec-0029">Description of the intervention</h3> <p>Therapy of acute pericarditis should always be targeted as much as possible to the underlying aetiology. In idiopathic pericarditis, treatment aims to manage the symptoms of the acute episode and to then prevent subsequent recurrences. For a long time, high‐dose steroids were the mainstay of treatment. Yet, high‐dose steroids caused numerous serious adverse effects (<a href="./references#CD010652-bbs2-0063" title="ShabetaiR . Recurrent pericarditis. Circulation2005;112(13):1921‐3. ">Shabetai 2005</a>), and their prolonged use has actually worsened the prognosis by increasing the recurrence rate of pericarditis and lengthening the course of the disease (<a href="./references#CD010652-bbs2-0026" title="ArtomG , Koren‐MoragN , SpodickDH , BrucatoA , GuindoJ , Bayes‐de‐LunaA , et al. Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi‐centre all‐case analysis. European Heart Journal2005;26(7):723‐7. ">Artom 2005</a>; <a href="./references#CD010652-bbs2-0014" title="ImazioM , DemichelisB , ParriniI , CecchiE , DemarieD , GhisioA , et al. Management, risk factors, and outcomes in recurrent pericarditis. The American Journal of Cardiology2005;96(5):736‐9. [PUBMED: 16125506] ">Imazio 2005b</a>; <a href="./references#CD010652-bbs2-0044" title="ImazioM , BrucatoA , TrincheroR , ShabetaiR , SpodickD , AdlerY . Corticosteroid therapy for pericarditis: a double‐edged sword. Nature Clinical Practice. Cardiovascular Medicine2008;5(3):118‐9. ">Imazio 2008</a>). Therefore, identifying interventions with a safer adverse effect profile was essential in order avoid worsening the natural course of recurrent pericarditis in other ways. </p> <p>Episodes of pericarditis are currently treated with aspirin or other NSAIDs and with steroids for refractory cases (<a href="./references#CD010652-bbs2-0052" title="MaischB , SeferovićPM , RistićAD , ErbelR , RienmüllerR , AdlerY , et al. Guidelines on the diagnosis and management of pericardial diseases: executive summary. European Heart Journal2004;25(7):587‐610. ">Maisch 2004</a>; <a href="./references#CD010652-bbs2-0064" title="Soler‐SolerJ , Sagrista‐SauledaJ , Permanyer‐MiraldaG . Relapsing pericarditis. Heart2004;90(11):1364‐8. ">Soler‐Soler 2004</a>). Colchicine has been used for the prevention of recurrences (<a href="./references#CD010652-bbs2-0009" title="BrucatoA , BrambillaG , AdlerY , SpodickDH , CanesiB . Therapy for recurrent acute pericarditis: a rheumatological solution?. Clinical and Experimental Rheumatology2006;24(1):45‐50. [PUBMED: 16539818] ">Brucato 2006</a>). </p> <p>Colchicine has anti‐inflammatory actions and antiproliferative effects (<a href="./references#CD010652-bbs2-0058" title="RobertAT . Colchicine update: 2008. Seminars in Arthritis and Rheumatism2009;38(6):411‐9. ">Robert 2009</a>). It inhibits many of the functions of neutrophils, such as the adhesion to endothelium and the release of a chemotactic factor from neutrophil lysosomes (<a href="./references#CD010652-bbs2-0055" title="NukiG . Colchicine: its mechanism of action and efficacy in crystal‐induced inflammation. Current Rheumatology Reports2008;10(3):218‐27. ">Nuki 2008</a>). </p> <p>Colchicine is considered a safe treatment in the treatment dose (<a href="./references#CD010652-bbs2-0043" title="ImazioM , BrucatoA , AdlerY , BrambillaG , ArtomG , CecchiE , et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. American Journal of Cardiology2007;100(6):1026‐8. ">Imazio 2007</a>), however, in high doses, it has many toxic effects and, in addition, it has a narrow therapeutic window (<a href="./references#CD010652-bbs2-0058" title="RobertAT . Colchicine update: 2008. Seminars in Arthritis and Rheumatism2009;38(6):411‐9. ">Robert 2009</a>). The maximum therapeutic dose is 4 mg/24 hours, while a fatal dose can be as low as 7 mg/24 hours with a higher fatality rate if the dose exceeds 0.5 ‐ 0.8 mg/kg (<a href="./references#CD010652-bbs2-0054" title="NielE , ScherrmannJM . Colchicine today. Joint Bone Spine2006;73(6):672‐8. ">Niel 2006</a>; <a href="./references#CD010652-bbs2-0031" title="CoccoG , ChuDC , PandolfiS . Colchicine in clinical medicine. A guide for internists. European Journal of Internal Medicine2010;21(6):503‐8. [PUBMED: 21111934] ">Cocco 2010</a>; <a href="./references#CD010652-bbs2-0035" title="FinkelsteinY , AksSE , HutsonJR , JuurlinkDN , NguyenP , Dubnov‐RazG , et al. Colchicine poisoning: the dark side of an ancient drug. Clinical Toxicology2010;48(5):407‐14. ">Finkelstein 2010</a>). The parenteral use increases the risk of mortality and is not used in clinical practice (<a href="./references#CD010652-bbs2-0031" title="CoccoG , ChuDC , PandolfiS . Colchicine in clinical medicine. A guide for internists. European Journal of Internal Medicine2010;21(6):503‐8. [PUBMED: 21111934] ">Cocco 2010</a>). Overdose is associated with gastrointestinal, hepatic, renal, neuromuscular and cerebral toxicity; bone marrow damage; and high mortality (<a href="./references#CD010652-bbs2-0055" title="NukiG . Colchicine: its mechanism of action and efficacy in crystal‐induced inflammation. Current Rheumatology Reports2008;10(3):218‐27. ">Nuki 2008</a>; <a href="./references#CD010652-bbs2-0035" title="FinkelsteinY , AksSE , HutsonJR , JuurlinkDN , NguyenP , Dubnov‐RazG , et al. Colchicine poisoning: the dark side of an ancient drug. Clinical Toxicology2010;48(5):407‐14. ">Finkelstein 2010</a>). Colchicine is excreted mainly by the liver after 20 to 40 hours (<a href="./references#CD010652-bbs2-0054" title="NielE , ScherrmannJM . Colchicine today. Joint Bone Spine2006;73(6):672‐8. ">Niel 2006</a>) and can accumulate in people with advanced liver disease (<a href="./references#CD010652-bbs2-0060" title="RudiJ , RaedschR , GerteisC , SchlenkerT , PlachkyJ , Walter‐SackI , et al. Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long‐term treatment. Scandinavian Journal of Gastroenterology1994;29(4):346‐51. [PUBMED: 8047810] ">Rudi 1994</a>). </p> <p>The recommended dose of colchicine used in gout and in recurrent pericarditis is 1 mg/day by oral administration (<a href="./references#CD010652-bbs2-0024" title="AdolphRJ . Old drugs with new uses. Colchicine for treatment of recurrent pericarditis. Circulation1990;82(4):1505‐6. ">Adolph 1990</a>; <a href="./references#CD010652-bbs2-0006" title="AdlerY , FinkelsteinY , GuindoJ , Rodriguez de la SernaA , ShoenfeldY , Bayes‐GenisA , et al. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation1998;97(21):2183‐5. [PUBMED: 9626180] ">Adler 1998</a>; <a href="./references#CD010652-bbs2-0031" title="CoccoG , ChuDC , PandolfiS . Colchicine in clinical medicine. A guide for internists. European Journal of Internal Medicine2010;21(6):503‐8. [PUBMED: 21111934] ">Cocco 2010</a>). Analgesia with colchicine is evident within 12 to 14 hours of oral administration (<a href="./references#CD010652-bbs2-0046" title="ImazioM , BrucatoA , TrincheroR , SpodickD , AdlerY . Colchicine for pericarditis: hype or hope?. European Heart Journal2009;30(5):532‐9. [PUBMED: 19190012] ">Imazio 2009</a>). The most common adverse effects of the therapeutic dose are nausea, vomiting, diarrhoea and abdominal pain (<a href="./references#CD010652-bbs2-0054" title="NielE , ScherrmannJM . Colchicine today. Joint Bone Spine2006;73(6):672‐8. ">Niel 2006</a>). </p> </section> <section id="CD010652-sec-0030"> <h3 class="title" id="CD010652-sec-0030">How the intervention might work</h3> <p>Colchicine is used in treating several inflammatory diseases such as gout and familial Mediterranean fever (FMF) (<a href="./references#CD010652-bbs2-0034" title="FamaeyJP . Colchicine in therapy. State of the art and new perspectives for an old drug. Clinical and Experimental Rheumatology1988;6(3):305‐17. [PUBMED: 3052972] ">Famaey 1988</a>; <a href="./references#CD010652-bbs2-0054" title="NielE , ScherrmannJM . Colchicine today. Joint Bone Spine2006;73(6):672‐8. ">Niel 2006</a>). Considering the possible autoimmune inflammatory pathophysiology of recurrent pericarditis (<a href="./references#CD010652-bbs2-0029" title="CaforioALP , BrucatoA , DoriaA , BrambillaG , AngeliniA , GhirardelloA , et al. Anti‐heart and anti‐intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart2010;96(10):779‐84. ">Caforio 2010</a>; <a href="./references#CD010652-bbs2-0030" title="CantariniL , ImazioM , BriziMG , LucheriniOM , BrucatoA , CimazR , et al. Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clinical Reviews in Allergy and Immunology2013;44(1):6‐13. ">Cantarini 2013</a>), and its response to immunosuppressive and anti‐inflammatory treatment (<a href="./references#CD010652-bbs2-0053" title="MarcolongoR , RussoR , LavederF , NoventaF , AgostiniC . Immunosuppressive therapy prevents recurrent pericarditis. Journal of the American College of Cardiology1995;26(5):1276‐9. ">Marcolongo 1995</a>), it is deemed acceptable and logical to determine the effects of colchicine in the management of recurrent pericarditis. </p> </section> <section id="CD010652-sec-0031"> <h3 class="title" id="CD010652-sec-0031">Why it is important to do this review</h3> <p>People with recurrent pericarditis can have a number of relapses over many years, causing severe chest pain. These episodes of pain limit both the functionality of patients and their quality of life, causing both a social and psychological burden for the patients and an economic burden on the hospitals taking care of them (<a href="./references#CD010652-bbs2-0064" title="Soler‐SolerJ , Sagrista‐SauledaJ , Permanyer‐MiraldaG . Relapsing pericarditis. Heart2004;90(11):1364‐8. ">Soler‐Soler 2004</a>). The high incidence of recurrent pericarditis in almost one‐third of patients with acute pericarditis increases this burden. Therefore, there is a need to find and examine therapies that decrease the number of recurrences. </p> <p>Observational studies have shown that colchicine might be effective in treating recurrent pericarditis (<a href="./references#CD010652-bbs2-0059" title="Rodríguez de la SernaA , Guindo SoldevilaJ , Martí ClaramuntV , Bayés de LunaA . Colchicine for recurrent pericarditis. Lancet1987;2(8574):1517. ">Rodríguez de la Serna 1987</a>; <a href="./references#CD010652-bbs2-0013" title="GuindoJ , Rodriguez de la SernaA , RamioJ , deMiguel DiazMA , SubiranaMT , Perez AyusoMJ , et al. Recurrent pericarditis. Relief with colchicine. Circulation1990;82(4):1117‐20. [PUBMED: 2205414] ">Guindo 1990</a>; <a href="./references#CD010652-bbs2-0017" title="MillaireA , deGrooteP , DecoulxE , GoullardL , DuclouxG . Treatment of recurrent pericarditis with colchicine. European Heart Journal1994;15(1):120‐4. [PUBMED: 8174571] ">Millaire 1994</a>; <a href="./references#CD010652-bbs2-0064" title="Soler‐SolerJ , Sagrista‐SauledaJ , Permanyer‐MiraldaG . Relapsing pericarditis. Heart2004;90(11):1364‐8. ">Soler‐Soler 2004</a>; <a href="./references#CD010652-bbs2-0014" title="ImazioM , DemichelisB , ParriniI , CecchiE , DemarieD , GhisioA , et al. Management, risk factors, and outcomes in recurrent pericarditis. The American Journal of Cardiology2005;96(5):736‐9. [PUBMED: 16125506] ">Imazio 2005b</a>; <a href="./references#CD010652-bbs2-0009" title="BrucatoA , BrambillaG , AdlerY , SpodickDH , CanesiB . Therapy for recurrent acute pericarditis: a rheumatological solution?. Clinical and Experimental Rheumatology2006;24(1):45‐50. [PUBMED: 16539818] ">Brucato 2006</a>). However, RCTs have only recently studied the effect of colchicine on pericarditis. Therefore, there is a need to systematically assess and critically appraise these trials in order to obtain a more definite clinical answer for both patients and clinicians dealing with recurrent pericarditis. </p> <p>A similar review has been published in the <i>Heart</i> journal (<a href="./references#CD010652-bbs2-0047" title="ImazioM , BrucatoA , FornoD , FerroS , BelliR , TrincheroR , et al. Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta‐analysis. Heart2012;98(14):1078‐82. ">Imazio 2012</a>). The main differences in our review are that we did not include postcardiac injury syndromes due to the different aetiology and pathophysiology from acute or recurrent pericarditis. In addition, we analysed trials of acute pericarditis separately from trials of recurrent pericarditis. We mention any differences between our review and the <i>Heart</i> journal review explicitly in the section '<a href="#CD010652-sec-0104">Agreements and disagreements with other studies or reviews</a>'. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010652-sec-0032" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010652-sec-0032"></div> <p>To review all randomised controlled trials (RCTs) that assess the effects of colchicine alone or combined, compared to any other intervention to prevent further recurrences of pericarditis, in people with acute or recurrent pericarditis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010652-sec-0033" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010652-sec-0033"></div> <section id="CD010652-sec-0034"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010652-sec-0035"> <h4 class="title">Types of studies</h4> <p>We will include RCTs with any length of follow‐up, and we will not impose any limitations on language or publication status. </p> </section> <section id="CD010652-sec-0036"> <h4 class="title">Types of participants</h4> <p> <ol id="CD010652-list-0001"> <li> <p>People with acute idiopathic pericarditis treated to prevent recurrences.</p> </li> <li> <p>People with recurrent idiopathic pericarditis who have had a documented episode of acute pericarditis, defined by any clinically valid diagnostic criteria such as described in the '<a href="#CD010652-sec-0024">Description of the condition</a>' section and who have evidence of recurrent pericarditis. </p> </li> </ol> </p> <p>We included participants regardless of the number of pericarditis recurrences, gender, age or ethnicity. We excluded acute or recurrent pericarditis that has bacterial or neoplastic causes, as in these cases the known cause has to be treated and managed. We excluded pericarditis as a result of postcardiac injury such as postmyocardial infarction pericarditis (Dressler's syndrome), postpericardiotomy syndrome and post‐traumatic pericarditis. </p> </section> <section id="CD010652-sec-0037"> <h4 class="title">Types of interventions</h4> <p> <ol id="CD010652-list-0002"> <li> <p>Colchicine: in any dose, duration, intensity or means of administration and alongside any additional therapy, on the condition that the additional therapy was also used at the same or similar dose in the control group. </p> </li> <li> <p>Controls: any inactive control intervention (e.g. placebo or no treatment) or any active control intervention (e.g. aspirin, NSAIDs or steroids). </p> </li> </ol> </p> </section> <section id="CD010652-sec-0038"> <h4 class="title">Types of outcome measures</h4> <p>We considered study eligibility regardless of the outcomes investigated or presented.</p> <section id="CD010652-sec-0039"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010652-list-0003"> <li> <p>Time to first recurrence expressed using hazard ratios (HRs).</p> </li> <li> <p>Adverse effects of colchicine: general and specific during treatment and on withdrawal of treatment. </p> </li> </ol> </p> </section> <section id="CD010652-sec-0040"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010652-list-0004"> <li> <p>Rate of first recurrence of pericarditis as expressed by the risk ratio (RR) at the following periods: short term (six months), medium term (12 months) and long term (splitting &gt; 12 months into categories e.g. 18 months, 24 months). </p> </li> <li> <p>Symptom relief during pericarditis episode.</p> </li> </ol> </p> </section> </section> </section> <section id="CD010652-sec-0041"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010652-sec-0042"> <h4 class="title">Electronic searches</h4> <p>SA and the Trials Search Co‐ordinator (TSC) of the Cochrane Heart Group (CHG) searched the following databases on 4 August 2014. </p> <p> <ul id="CD010652-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL, Issue 7 of 12, 2014 on <i>The Cochrane Library</i>). </p> </li> <li> <p>MEDLINE (Ovid, 1946 to July week 4, 2014).</p> </li> <li> <p>EMBASE Classic and EMBASE (Ovid, 1947 to 2014 week 31).</p> </li> <li> <p>Conference Proceedings Citation Index‐ Science (CPCI‐S) on Web of Science (Thomson Reuters, 1990 to 5 August 2014). </p> </li> </ul> </p> <p>The search did not include any language or time restriction. The "not" Boolean was not used. The search strategies used can be found in <a href="./appendices#CD010652-sec-0111">Appendix 1</a>. </p> <p>The RCT filter for MEDLINE is the Cochrane sensitivity‐maximising RCT filter, and for EMBASE, terms as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> have been applied (<a href="./references#CD010652-bbs2-0051" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins, JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>). </p> </section> <section id="CD010652-sec-0043"> <h4 class="title">Searching other resources</h4> <p>We searched the following three databases of on‐going trials on 5 August 2013.</p> <p> <ul id="CD010652-list-0006"> <li> <p>International Clinical Trials Registry Platform Search Portal (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>). </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>). </p> </li> <li> <p>European Union Clinical Trials Register (www.clinicaltrialsregister.eu).</p> </li> </ul> </p> <p>We examined the references of all identified studies to look for more studies. We contacted the first author of each included study for information about trials that had not been published. </p> </section> </section> <section id="CD010652-sec-0044"> <h3 class="title" id="CD010652-sec-0044">Data collection and analysis</h3> <section id="CD010652-sec-0045"> <h4 class="title">Selection of studies</h4> <p>Two review authors (SA, MQ) independently reviewed the titles and abstracts identified from the searches done by SA and the TSC. SA and MQ obtained full‐text publications when necessary, and determined eligibility independently. The opinion of a third author (JBC) was sought when encountered with one of the unpublished trials and dealing with studies of postcardiac injury syndrome. We did not need to contact study authors for further information. </p> </section> <section id="CD010652-sec-0046"> <h4 class="title">Data extraction and management</h4> <p>Two authors (SA, GJI) independently assessed the methodological quality and extracted data from the studies fulfilling the inclusion criteria. The data were extracted using an agreed data extraction form. We included essential items mentioned in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> table 7.3a (<a href="./references#CD010652-bbs2-0039" title="HigginsJPT , Deeks JJ(editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>) regarding methods, participants, intervention, outcomes and results. The data extraction form was piloted by (SA) on one of the included studies. </p> <section id="CD010652-sec-0047"> <h5 class="title">'Summary of findings' table</h5> <p>We used the GRADE approach, adopted by The Cochrane Collaboration, to interpret findings (<a href="./references#CD010652-bbs2-0061" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011</a>). We used the GRADE profiler (GRADEpro) (<a href="./references#CD010652-bbs2-0037" title="BrozekJ , OxmanA , SchünemannH . GRADEpro. Version 3.2. The GRADE Working Group, 2008. ">GRADEpro 2008</a>) programme to import data from Review Manager 5 (<a href="./references#CD010652-bbs2-0057" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>), to create the 'Summary of findings' tables. The GRADE system involves an assessment of the quality of a body of evidence for each individual outcome. In GRADEpro the quality of evidence for each outcome is separately rated as high, moderate, low and very low quality. The rate of the outcomes of all randomised trials were regarded as high and downgraded depending on: limitations in the design of the selected studies, high risk of bias, indirectness of evidence, unexplained heterogeneity, imprecision of results, and high probability of publication bias. The outcome‐specific ratings were produced in tables by GRADEpro and give information about the overall quality of evidence from each included study. We selected all primary outcomes for inclusion in the 'Summary of findings' table. </p> </section> </section> <section id="CD010652-sec-0048"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (SA, GJI) independently assessed the risk of bias in each study using the 'Risk of bias' tool of The Cochrane Collaboration. A third author (JBC) was consulted about differences in opinion about grading the risk of bias in the blinding domain. </p> <section id="CD010652-sec-0049"> <h5 class="title">Risk of bias for an outcome within a study (across domains)</h5> <p>The specific characteristics assessed included random sequence generation, allocation concealment, blinding of participants, personnel and outcome assessors, incomplete outcome data, selective reporting and other sources of bias. </p> </section> <section id="CD010652-sec-0050"> <h5 class="title">Risk of bias for an outcome across studies (e.g. for a meta‐analysis)</h5> <p>We summarised the risk of bias of the outcomes for each domain included in the meta‐analyses and incorporated judgements into the 'Summary of findings' tables. We expressed the risk of bias in each domain using the following judgements: 'low risk', 'high risk' or 'unclear risk' of bias, as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> table 8.5.d (<a href="./references#CD010652-bbs2-0040" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>). </p> </section> </section> <section id="CD010652-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We followed recommendations of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> sections 9.2 and 9.4 (<a href="./references#CD010652-bbs2-0041" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011c</a>) for measuring the effects of different data types. </p> <section id="CD010652-sec-0052"> <h5 class="title">Time‐to‐recurrence</h5> <p>We used hazard ratios (HRs) with 95% confidence intervals (CIs) to express events such as time until the first recurrence of pericarditis. We used the methods described in <a href="./references#CD010652-bbs2-0067" title="TierneyJF , StewartLA , GhersiD , BurdettS , SydesMR . Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials2007;8:16. ">Tierney 2007</a> to calculate approximate hazard ratios. </p> </section> <section id="CD010652-sec-0053"> <h5 class="title">Dichotomous data</h5> <p>We calculated the risk ratio (RR) with 95% CI for binary data (i.e. recurrence rates, adverse effects). We calculated the number needed to treat (NNT) from the absolute risk reduction (ARR) if available. </p> </section> <section id="CD010652-sec-0054"> <h5 class="title">Continuous data</h5> <p>We did not encounter any continuous data.</p> </section> <section id="CD010652-sec-0055"> <h5 class="title">Counts and rates</h5> <p>We expressed count data (i.e. recurrence rate of pericarditis) as rate ratios.</p> </section> </section> <section id="CD010652-sec-0056"> <h4 class="title">Unit of analysis issues</h4> <p>Our primary outcome was any recurrence of pericarditis and our unit of analysis was the patient. We did not encounter any cluster trials, studies with multiple treatment groups or cross‐over trials. </p> </section> <section id="CD010652-sec-0057"> <h4 class="title">Dealing with missing data</h4> <p>There was no issues with missing data in the included studies.</p> </section> <section id="CD010652-sec-0058"> <h4 class="title">Assessment of heterogeneity</h4> <section id="CD010652-sec-0059"> <h5 class="title">Clinical heterogeneity</h5> <p>Clinical heterogeneity might be due to differences in the population i.e. age or ethnicity, or differences in interventions i.e. different doses, duration, intensity or delivery method, or due to differences in the way outcomes are measured, such as different criteria for pericarditis recurrence. All studies with outlying situations will be fully discussed. A subgroup analysis of different causes of clinical heterogeneity is planned. </p> <p>People with acute pericarditis and recurrent pericarditis have a different baseline risk for recurrence, as patients who already have experienced recurrent episodes of pericarditis are more susceptible to recurrence (<a href="./references#CD010652-bbs2-0064" title="Soler‐SolerJ , Sagrista‐SauledaJ , Permanyer‐MiraldaG . Relapsing pericarditis. Heart2004;90(11):1364‐8. ">Soler‐Soler 2004</a>; <a href="./references#CD010652-bbs2-0063" title="ShabetaiR . Recurrent pericarditis. Circulation2005;112(13):1921‐3. ">Shabetai 2005</a>). Therefore, we analysed the two patient groups separately for any outcome comparing recurrence rates, as specified in the protocol. We combined outcomes of adverse effects and symptom relief for people with acute and recurrent pericarditis as they are not affected by the risk for recurrence. </p> </section> <section id="CD010652-sec-0060"> <h5 class="title">Methodological heterogeneity</h5> <p>We investigated all included trials for unpredicted outlying methods. All included studies were methodologically comparable. </p> </section> <section id="CD010652-sec-0061"> <h5 class="title">Statistical heterogeneity</h5> <p>We investigated statistical heterogeneity by visual inspection and carrying out both the Chi<sup>2</sup> test and the I<sup>2</sup> test. The Chi<sup>2</sup> test with a small P value provides evidence of heterogeneity. However, because of the low power of the Chi<sup>2</sup> test we used a P value of 0.1 to determine statistical significance. We used the I<sup>2</sup> statistic to quantify statistical inconsistency and assess the impact of heterogeneity on the meta‐analysis. An I<sup>2</sup> &gt; 50% was set to demonstrate high heterogeneity. </p> </section> </section> <section id="CD010652-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>As the number of included studies was less than ten studies we did not attempt to use the funnel plot test, because it would have too low a power to distinguish chance from real asymmetry (<a href="./references#CD010652-bbs2-0066" title="SterneJAC , EggerM , MoherD (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Sterne 2011</a>). </p> </section> <section id="CD010652-sec-0063"> <h4 class="title">Data synthesis</h4> <p>We pooled data in meta‐analyses where they were available and it was clinically acceptable to do so. We used Review Manager software for meta‐analyses (<a href="./references#CD010652-bbs2-0057" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). For the statistical analyses, we used the fixed‐effect model with 95% CI as the main analysis. In addition, we undertook a sensitivity analysis using the random‐effects model as per protocol. </p> </section> <section id="CD010652-sec-0064"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD010652-sec-0065"> <h5 class="title">1. Subgroup analyses</h5> <p>We intended to do a subgroup meta‐analyses for:</p> <p> <ol id="CD010652-list-0007"> <li> <p>dosage of colchicine used; and</p> </li> <li> <p>age of patient (children and adults).</p> </li> </ol> </p> <p>However, there was not enough data to perform any of the subgroup analyses.</p> </section> <section id="CD010652-sec-0066"> <h5 class="title">2. Investigation of heterogeneity</h5> <p>We did not encounter high levels of heterogeneity.</p> </section> </section> <section id="CD010652-sec-0067"> <h4 class="title">Sensitivity analysis</h4> <p> <ol id="CD010652-list-0008"> <li> <p>We performed a sensitivity analyses of fixed‐effect versus random‐effects, as per protocol. </p> </li> <li> <p>It was not possible to perform a sensitivity analyses of studies judged to be at high risk of bias. </p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010652-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010652-sec-0068"></div> <section id="CD010652-sec-0069"> <h3 class="title">Description of studies</h3> <section id="CD010652-sec-0070"> <h4 class="title">Results of the search</h4> <p>We identified a total of 732 articles from the search of CENTRAL, MEDLINE, EMBASE, Web of Science and clinical trial registers. Removal of duplicates left 481 articles for screening, including 68 abstracts of conferences. From the 532 screened articles we excluded 464 and retrieved 68 full papers. A further 63 were not RCTs or were RCTs not related to our review. This left four trials that met the inclusion criteria (<a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>; <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>; <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>; <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>) and one study awaiting classification (<a href="./references#CD010652-bbs2-0020" title="Imazio , Massimo , Belli , Riccardo , Brucato , Antonio , et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP‐2): a multicentre, double‐blind, placebo‐controlled, randomised trial. The Lancet 28 June 2014;383(9936):2232‐2237. ">Imazio 2014</a>). We did not identify any additional eligible trials after scanning the reference lists of full‐text papers. </p> <p>The process with reasons for exclusions is described in <a href="#CD010652-fig-0001">Figure 1</a> and a list of excluded trials is given in the table '<a href="./references#CD010652-sec-0120" title="">Characteristics of excluded studies</a>'. </p> <div class="figure" id="CD010652-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010652-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>Additionally, we identified one on‐going RCT registered on the European Union Clinical Trials Register <a href="./references#CD010652-bbs2-0021" title="EUCTR2009‐011258‐16‐ES . The efficacy of colchicine administration in the first sign of pericarditis to avoid recurrences [Eficacia de la colchicina administrada en el primer brote de pericarditis para evitar la aparición de recidivas]. http://apps.who.int/trialsearch/trial.aspx?trialid=EUCTR2009‐011258‐16‐ES (accessed 20 March 2014). ">EUCTR2009‐011258‐16‐ES</a>. </p> </section> <section id="CD010652-sec-0071"> <h4 class="title">Included studies</h4> <p>The four included trials were conducted between 2005 and 2013. The trials, <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> were done by the same research group and some members of this research group were also involved in <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>. All four studies were parallel design, RCTs. Two studies were double‐blind (<a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>; <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>) and the other two (<a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>; <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>) were open‐label. Two studies addressed people with recurrent pericarditis (<a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>; <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>), whereas (<a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>; <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>) addressed patients with acute pericarditis. </p> <p>The mean follow‐up of all included studies was from 20 to 24 months. All studies were conducted in secondary care settings in Italy. <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> are multicentre studies, <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> was conducted in two health centres and <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> was conducted in one hospital. All trials were done by the same research group. All studies were published in English. </p> <section id="CD010652-sec-0072"> <h5 class="title">Population</h5> <p>We included a total of 564 participants in this review. Of these, 204 participants were recruited in the trials for recurrent pericarditis and 360 for acute pericarditis. Only patients with a first recurrence of pericarditis were recruited in <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> and <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>. Diagnosed pericarditis was either idiopathic (80% to 85%) or autoimmune (15% to 20%) in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>, <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> and <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>). In <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>, 77% of included participants had idiopathic pericarditis, 3% autoimmune pericarditis and 20% had postcardiac injury syndrome. Although we initially decided to exclude patients with postcardiac injury syndrome, it was not possible in <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> to analyse data of patients with idiopathic pericarditis only.<br/> <br/> All included participants had chest pain as the main symptom. The main signs were ECG changes (70% to 85%), pericardial effusion (60% to 68%) and pericardial rub (20% to 35%). The number of female participants was slightly higher in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>, <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> and <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>, making up 52% to 57% in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and 62% to 69% in <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>. In <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>, female participants made up 40%. </p> <p>The mean ages in years (standard errors are given in brackets) of the included patients in each group are as follows. </p> <p> <ul id="CD010652-list-0009"> <li> <p><a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>: control 57.2 (19.6), colchicine 56.5 (18.2). </p> </li> <li> <p><a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>: control 51.2 (16.3), colchicine 56.4 (16.9). </p> </li> <li> <p><a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>: control 47.3 (14.4), colchicine 47.9 (15.4). </p> </li> <li> <p><a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>: control 50.7 (17.5), colchicine 53.5 (16.2). </p> </li> </ul> </p> <p>No study included children, elderly people, pregnant or lactating women or women of childbearing age who were not using contraception. People with severe liver disease, serum creatinine levels greater than 221 µmol/L (2.5 mg/dL), gastrointestinal disease; or known hypersensitivity to colchicine were also excluded.<br/> <br/> Baseline characteristics of participants in the trials are shown in <a href="#CD010652-tbl-0006">Table 1</a>. </p> <div class="table" id="CD010652-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Baseline characteristics</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Characteristics</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. "><b>Imazio 2005</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. "><b>Imazio 2005a</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. "><b>Imazio 2011</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. "><b>Imazio 2013</b> </a> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Colchicine</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Colchicine</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Colchicine</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Colchicine</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56.5 ± 18.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57.2 ± 19.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56.4 ± 16.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51.2 ±16.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47.9 ± 15.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47.3 ± 14.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.5 ± 16.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50.7 ± 17.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Male</p> <p>Female</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46.7%</p> <p>53.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43.3%</p> <p>56.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> <p>62%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31%</p> <p>69%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43%</p> <p>57%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48%</p> <p>52%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.2%</p> <p>40.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61.7%</p> <p>38.3%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Region</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pericarditic chest pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.2%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pericardial rub</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.7%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ECG changes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n.a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n.a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.7%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pericardial effusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68.3%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiac tamponade</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n.a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n.a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Idiopathic pericarditis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.5%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Autoimmune pericarditis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.3%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroid use on index attack</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD010652-sec-0073"> <h5 class="title">Intervention</h5> <p>The intervention was oral colchicine tablets in all included trials. Colchicine was given at a loading dose of 1 mg every 12 hours for the first day of treatment, except <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> which did not have a loading dose. A maintenance dose of 0.5 mg twice daily was then continued for six months in <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> and <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and three months in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>. People who weighed less than 70 kg, had the loading dose changed to 0.5 mg every 12 hours, followed by a maintenance dose of 0.5 mg once daily. </p> <p>Participants in both the intervention and control group in all included studies received oral aspirin at a dose of 800 mg every six to eight hours for seven to 10 days. The dosage of aspirin was then gradually tapered down over a period of three to four weeks. In <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>, ibuprofen 600 mg was additionally offered as an alternative to aspirin. People who had contraindications to aspirin received prednisone for four weeks with gradual tapering down. The dose of prednisone given was 1 to 1.5 mg/kg in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>, and 0.2 to 0.5 mg/kg in <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>. </p> <p>Participants in both the intervention and control group also received a proton‐pump inhibitor (PPI) while they were on aspirin or another NSAID. The dose of the PPI was not mentioned in the studies. </p> <p>The control group in <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> also received placebo tablets that were identical in colour, shape, and taste to the colchicine tablets and were provided in identical packs. The control group in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> did not receive a placebo. </p> </section> <section id="CD010652-sec-0074"> <h5 class="title">Outcomes</h5> <p>The recurrence of pericarditis was reported in all studies using survival analysis with Kaplan‐Meier event‐free curves. The endpoint chosen in the studies was the rate of pericarditis recurrence at 18 months. Recurrences were defined in all studies by chest pain with at least one other objective outcome measure such as pericardial friction rub, widespread ST‐segment elevation or PR‐segment depression on ECG, new or worsening pericardial effusion on echocardiography and raised inflammatory markers such as white blood cell count, erythrocyte sedimentation rate (ESR) or C‐reactive protein (CRP). </p> <p>All studies reported on the type and number of adverse events.</p> <p>Relief from the symptoms of pericarditis at 72 hours was a reported secondary outcome in all included studies. Additonally, <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> reported remission rate at one week, number of recurrences, time to first recurrence, disease‐related hospitalisation, cardiac tamponade, and rates of constrictive pericarditis as other secondary outcomes. </p> <p>The main characteristics of the included studies are summarised in the table <a href="./references#CD010652-sec-0119" title="">Characteristics of included studies</a>. </p> <p>All trials stated that outcomes were assessed and measured by blinded expert cardiologists.</p> </section> </section> <section id="CD010652-sec-0075"> <h4 class="title">Excluded studies</h4> <p>The main reason for excluding studies was if they were not RCTs and if they were literature reviews. We excluded two RCTs (<a href="./references#CD010652-bbs2-0011" title="FinkelsteinY , ShemeshJ , MahlabK , AbramovD , Bar‐ElY , SagieA , et al. Colchicine for the prevention of postpericardiotomy syndrome. Herz2002;27(8):791‐4. [PUBMED: 12574898] ">Finkelstein 2002</a>; <a href="./references#CD010652-bbs2-0015" title="ImazioM , CecchiE , TrincheroR . Colchicine for the prevention of the postpericardiotomy syndrome: the COPPS trial. International Journal of Cardiology2007; Vol. 121, issue 2:198‐9. [PUBMED: 17134774] ">Imazio 2007b</a>) as they were of postpericardectomy syndrome which is not relevant to this systematic review. The main characteristics of the excluded studies are in the table '<a href="./references#CD010652-sec-0120" title="">Characteristics of excluded studies</a>'. </p> </section> </section> <section id="CD010652-sec-0076"> <h3 class="title">Risk of bias in included studies</h3> <p>In summary, <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> have been rated to have a low risk of bias and <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> have a moderate risk of bias. For details on the risk of bias in included studies see 'Risk of bias' table (<a href="./references#CD010652-sec-0119" title="">Characteristics of included studies</a>). The overall risk of bias is presented graphically in <a href="#CD010652-fig-0002">Figure 2</a> and summarised in <a href="#CD010652-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD010652-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010652-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010652-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010652-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010652-sec-0077"> <h4 class="title">Risk of bias across studies</h4> <p>We assessed the risk of bias for the reported outcomes using the GRADE approach. We created 'Summary of findings' tables using the Gradepro software. The quality of evidence was moderate for outcomes of pericarditis recurrence and low quality for total adverse events and symptom relief. Details of the risk of bias across studies can be found in: <a href="./full#CD010652-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD010652-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD010652-tbl-0003">summary of findings Table 3</a>; <a href="./full#CD010652-tbl-0004">summary of findings Table 4</a>; and <a href="./full#CD010652-tbl-0005">summary of findings Table 5</a>. </p> </section> <section id="CD010652-sec-0078"> <h4 class="title">Allocation</h4> <section id="CD010652-sec-0079"> <h5 class="title">Randomisation</h5> <p>There was no description of how randomisation had been achieved in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>. In <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> participants were assigned to treatment groups by a central computer–based automated sequence. In all studies, the sequence for allocation was based on permuted blocks with a block size of four. </p> <p>Overall, the baseline characteristics of participants in all studies in the intervention and control groups appeared similar after randomisation, as shown in <a href="#CD010652-tbl-0006">Table 1</a>. </p> </section> <section id="CD010652-sec-0080"> <h5 class="title">Allocation concealment</h5> <p>Allocation concealment was not reported in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> or <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>. In <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> allocation concealment was implemented by using sequentially numbered containers. <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> mentions that allocation was concealed from patients and investigators. </p> </section> </section> <section id="CD010652-sec-0081"> <h4 class="title">Blinding</h4> <section id="CD010652-sec-0082"> <h5 class="title">Blinding of participants and personnel</h5> <p>Both <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> had an open‐label design. <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> were double‐blinded RCTs for both participants and trial investigators. Additionally, the intervention and control tablets were reported to be identical in colour, shape and taste. </p> <p>The control intervention was given for only four to five weeks in all studies, whereas colchicine was given for six months (<a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>; <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>) or three months (<a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>; <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>). The study authors did not clarify if anything was given to the control group after the control intervention was stopped in order to maintain blinding. The unequal duration of intervention between the therapeutic and control group might have introduced blinding bias for the participants. </p> </section> <section id="CD010652-sec-0083"> <h5 class="title">Blinding of outcome assessors and data analysers</h5> <p>Clinical events were validated by an ad‐hoc committee of expert cardiologists who were blinded to participants’ allocation. Even for <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> that had open‐label designs, recurrences of pericarditis were assessed by blinded outcome assessors and required the presence of objective outcome measures (raised inflammatory markers or ECG changes). Therefore, we considered the risk of bias to be low. Data analyses were performed by an external committee blinded to treatment allocation. </p> </section> </section> <section id="CD010652-sec-0084"> <h4 class="title">Incomplete outcome data</h4> <p>The risk of attrition bias seemed low. Intention‐to‐treat (ITT) analysis was reported in all trials and all randomised participants were included in the final analyses and results. Colchicine therapy was discontinued due to adverse effects (mainly gastrointestinal symptoms) in five patients (8.3%) in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>, three patients (7%) in <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>, five patients (8%) in <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and fourteen patients (11.7%) in <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>. In the control group, four (6%) people in <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> discontinued therapy due to adverse effects and ten people (8.3%) in <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>. Whereas in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> no one in the control group withdrew from treatment. All patients who discontinued therapy were followed up for recurrences and were included in all analyses. </p> </section> <section id="CD010652-sec-0085"> <h4 class="title">Selective reporting</h4> <p>All reported outcomes were clinically relevant.</p> <p>All studies were done to assess the rate of recurrence of pericarditis with colchicine therapy and this has been reported as the main outcome in all studies.<br/> The secondary outcome of symptom persistence at 72 hours was subjectively chosen by the researchers. Symptoms were not reported at any point in time before or after the studied 72 hours. It was not possible to ensure that this time point was decided on before the trials were done or because it showed the most favourable results. Therefore, we considered the outcome of symptom relief to be of high risk of bias for selective reporting. </p> </section> <section id="CD010652-sec-0086"> <h4 class="title">Other potential sources of bias</h4> <p>No potential threats to validity had been detected, such as early trial termination or any imbalance in the baseline characteristics of the colchicine or control groups. </p> <p>No declarations of conflict of interest were made by the trial authors. The funding source had been reported in <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> to be the Italian National Healthcare System. <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>, <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> did not declare the funding source. </p> </section> </section> <section id="CD010652-sec-0087"> <h3 class="title" id="CD010652-sec-0087">Effects of interventions</h3> <p>See: <a href="./full#CD010652-tbl-0001"><b>Summary of findings for the main comparison</b> Time to recurrence of pericarditis</a>; <a href="./full#CD010652-tbl-0002"><b>Summary of findings 2</b> Adverse effects of colchicine</a>; <a href="./full#CD010652-tbl-0003"><b>Summary of findings 3</b> Recurrences in patients with recurrent pericarditis</a>; <a href="./full#CD010652-tbl-0004"><b>Summary of findings 4</b> Recurrence rate in patients with acute pericarditis</a>; <a href="./full#CD010652-tbl-0005"><b>Summary of findings 5</b> Symptom relief for pericarditis</a> </p> <section id="CD010652-sec-0088"> <h4 class="title">Time‐to‐recurrence</h4> <p>The time‐to‐recurrence has been expressed in HRs. The log HRs and their standard error have been obtained using the log‐rank analysis from a method provided by <a href="./references#CD010652-bbs2-0068" title="TrivellaM . Marialena Trivella. Personal Correspondence (email and conversation). [OTHER] ">Trivella 2012 [pers comm]</a>. We calculated the HRs using the generic inverse variance methods in Review Manager (<a href="./references#CD010652-bbs2-0057" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We included two trials (<a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>; <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>) with 204 participants in the meta‐analysis for participants with recurrent pericarditis over 18 months of follow‐up: HR 0.37; 95% CI (0.24 to 0.58); I<sup>2</sup>= 0%, fixed‐effect model (<a href="./references#CD010652-fig-0004" title="">Analysis 1.1</a>).<br/> <br/> We included two trials (<a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>; <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>) with 360 participants in the meta‐analysis participants with acute pericarditis over 18 months of follow‐up: HR 0.40; 95% CI (0.27 to 0.61); I<sup>2</sup>= 0%, fixed‐effect model (<a href="./references#CD010652-fig-0005" title="">Analysis 1.2</a>). </p> </section> <section id="CD010652-sec-0089"> <h4 class="title">Adverse effects of colchicine</h4> <p>All included studies reported on adverse events and their type. All adverse effects of colchicine were due to gastrointestinal intolerance, mainly consisting of diarrhoea but also other effects such as nausea, vomiting or abdominal pain. Two people in <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> experienced hepatotoxicity (an elevation of aminotransferase levels) and one person got alopecia. </p> <p>Similarly most adverse events in the control group were of gastrointestinal origin and one person in each <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a> experienced hepatotoxicity. No serious adverse effects have been reported. </p> <p>In <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> all adverse effects were recorded in the first week of treatment. No comment on the time of adverse events was made in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>, <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> or <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>. </p> <p>We pooled the results of 564 participants in all four included studies as they had similar baseline characteristics and the interventions were given in similar doses. </p> <section id="CD010652-sec-0090"> <h5 class="title">Total adverse event</h5> <p>A total of 29 people (10%) in the colchicine group and 23 people (8%) in the control group had adverse effects (RR 1.26; 95% CI (0.75 to 2.12) (P = 0.38); I<sup>2</sup> = 0%, fixed‐effect model (<a href="./references#CD010652-fig-0006" title="">Analysis 2.1</a>)). The absolute risk difference (ARD) for adverse effects between colchicine and NSAIDs was 2%. </p> </section> <section id="CD010652-sec-0091"> <h5 class="title">Adverse effects causing withdrawal of therapy</h5> <p>A total of 27 people out of 282 (9.6%) in the colchicine group had to stop therapy due to adverse effects. Almost everyone who had adverse effects with colchicine decided to stop therapy (27 out of 29). In the control group, 14 participants (5%) decided to stop therapy.<br/> The RR of adverse effects necessitating the stop of therapy was 1.87; 95% CI (1.02 to 3.41), (P = 0.04); I<sup>2</sup> = 5%, fixed‐effect model (<a href="./references#CD010652-fig-0007" title="">Analysis 2.2</a>), the ARD was 4.6%. </p> </section> </section> <section id="CD010652-sec-0092"> <h4 class="title">Recurrence rate</h4> <p>The recurrence rates have been reported by all included studies in a Kaplan‐Meier survival curve. Ideally, the recurrence rate should have been calculated using the individual patient data, however as these were not available, the data for recurrence rate has been extracted from the survival curves using the DigitizeIt software (<a href="./references#CD010652-bbs2-0032" title="DigitizeIt . DigitizeIt. Version 1.5. Köln : DigitizeIt , 2012. ">DigitizeIt 2012</a>). The shortcomings of data from Kaplan‐Meier curves is that it ignores the censored observations as it is not known whether the outcome event occurred after follow‐up ended. The Kaplan‐Meier curves do not show how many patients had the recurrence with each drop in the survival‐curve. Additionally, it does not take into account the time for the event to happen as participants may have joint the trial at different times (<a href="./references#CD010652-bbs2-0025" title="Altman , DG . Practical Statistics for Medical Research. London: Chapman and Hall, 1991. ">Altman 1991</a>). This might result in some inaccuracies in the results. </p> <p>The RR was calculated for the recurrence rates at time points of 6 months, 12 months and 18 months. </p> <section id="CD010652-sec-0093"> <h5 class="title">Recurrence rate in people with recurrent pericarditis</h5> <p>The recurrence rate for participants with recurrent pericarditis was reported in <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> and <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>. We combined the data of 204 participants of both trials to calculate the RR. </p> <p>Meta‐analysis for recurrences in participants with recurrent pericarditis at 6 months: RR 0.28; 95% CI (0.17 to 0.47); I<sup>2</sup>= 0%, fixed‐effect model (<a href="./references#CD010652-fig-0008" title="">Analysis 3.1</a>). </p> <p>Meta‐analysis for recurrences in participants with recurrent pericarditis at 12 months: RR 0.36; 95% CI (0.23 to 0.56); I<sup>2</sup>= 56%, fixed‐effect model (<a href="./references#CD010652-fig-0009" title="">Analysis 3.2</a>). </p> <p>Meta‐analysis for recurrences in participants with recurrent pericarditis at 18 months: RR 0.38; 95% CI (0.25 to 0.58); I<sup>2</sup>= 0%, fixed‐effect model (<a href="./references#CD010652-fig-0010" title="">Analysis 3.3</a>). </p> <p>The total number of people who had one further recurrence at 18 months in the colchicine group was 21 of 102 (21%) and 55 of 102 (54%) in the NSAIDs group. The ARD was 23%. The number needed to treat (NNT) to prevent one recurrence was 4.4. </p> </section> <section id="CD010652-sec-0094"> <h5 class="title">Recurrence rate in people with acute pericarditis</h5> <p>The recurrence rate for participants with acute pericarditis was reported in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>. We combined the data of 360 participants of both trials to calculate the RR. </p> <p>At 6 months the RR was 0.36; 95% CI (0.23 to 0.58) (<a href="./references#CD010652-fig-0011" title="">Analysis 4.1</a>). At 6 months, 20 patients (11%) in the colchicine group and 55 patients (31%) in the control group had a first recurrence. The ARD was 20%. </p> <p>At 12 months the RR was 0.40; 95% CI (0.26 to 0.61) (<a href="./references#CD010652-fig-0012" title="">Analysis 4.2</a>). At 12 months, 24 patients (13%) in the colchicine group and 60 patients (33%) in the control group had a first recurrence. The ARD was 20%. </p> <p>At 18 months the RR was 0.41; 95% CI (0.28 to 0.61) (<a href="./references#CD010652-fig-0013" title="">Analysis 4.3</a>). At 18 months, 27 patients (15%) In the colchicine group and 66 patients (37%) in the control group had a first recurrence. The ARD was 22% and NNT to prevent one recurrence was 4.5. </p> </section> </section> <section id="CD010652-sec-0095"> <h4 class="title">Symptom relief</h4> <p>All included trials assessed the effect of colchicine on patients' symptoms. Only symptom relief at 72 hours had been reported. </p> <p>The pooled RR for symptom relief at 72 hours was 1.40; 95% CI (1.26 to 1.56); I<sup>2</sup>= 0%, fixed‐effect model (<a href="./references#CD010652-fig-0014" title="">Analysis 5.1</a>). </p> </section> <section id="CD010652-sec-0096"> <h4 class="title">Assessment of heterogeneity</h4> <p>All the studies were clinically homogenous and had patients with similar baseline characteristics. All pooled estimates were statistically homogenous ( I<sup>2</sup>= 0%). The only exception was the pooled effect of symptom relief which had an I<sup>2</sup> = 89%. However, as there is no clinical heterogeneity this might be due to the low number of events in the control group in <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>. </p> </section> <section id="CD010652-sec-0097"> <h4 class="title">Subgroup analysis</h4> <p>We have not performed any subgroup analysis. See the '<a href="#CD010652-sec-0117">Differences between protocol and review</a>'. </p> <p>We had intended to analyse any paediatric population as a subgroup. However, no trial included people younger than 18 years. A review of all non‐randomised trials identified in the systematic review search (<a href="#CD010652-tbl-0007">Table 2</a>) showed that colchicine has been tried in children in 10 cases. In six children (<a href="./references#CD010652-bbs2-0006" title="AdlerY , FinkelsteinY , GuindoJ , Rodriguez de la SernaA , ShoenfeldY , Bayes‐GenisA , et al. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation1998;97(21):2183‐5. [PUBMED: 9626180] ">Adler 1998</a>; <a href="./references#CD010652-bbs2-0019" title="YazigiA , Abou‐CharafLC . Colchicine for recurrent pericarditis in children. Acta Paediatrica1998;87(5):603‐4. [PUBMED: 9641750] ">Yazigi 1998</a>; <a href="./references#CD010652-bbs2-0048" title="JurkoA , PokornyD , FarskaZ , SparcovaA . Colchicine in atypical forms of pericarditis in children. Advances in Heart failure; Proceedings of the 8th World Congress on Heart Failure ‐ Mechanisms and Management; 2002 July 13‐16; Washington, DC. Bologna: Medimond Medical, 2002:327‐34. ">Jurko 2002</a>) colchicine was effective in preventing further recurrences, however, it failed to show any effect in four other children <a href="./references#CD010652-bbs2-0018" title="RaatikkaM , PelkonenPM , KarjalainenJ , JokinenEV . Recurrent pericarditis in children and adolescents: report of 15 cases. Journal of the American College of Cardiology2003;42(4):759‐64. [PUBMED: 12932616] ">Raatikka 2003</a>. </p> <div class="table" id="CD010652-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Review of observational studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Author and date</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Study type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Results</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Conclusion</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0006" title="AdlerY , FinkelsteinY , GuindoJ , Rodriguez de la SernaA , ShoenfeldY , Bayes‐GenisA , et al. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation1998;97(21):2183‐5. [PUBMED: 9626180] ">Adler 1998</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 patients (36 men and 15 women; mean ± SD age, 40.8 ± 18.7 years) with recurrent pericarditis followed up for &lt; or = 10 years </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/day)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31 patients (60.7%) remained recurrence‐free.</p> <p>Drug withdrawal in 39 (76%) patients</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0007" title="AdlerY , GuindoJ , FinkelsteinY , KhouriA , AssaliA , Bayes‐GenisA , et al. Colchicine for large pericardial effusion. Clinical Cardiology1998;21(2):143‐4. [PUBMED: 9491960] ">Adler 1998a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two case reports</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a 26‐year‐old male and a 2‐year‐old girl with idiopathic pericarditis and pericardial effusion </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/day) for 1 month in the man and 6 months in the child</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No recurrences in 24 months follow‐up in the man and 6 months follow‐up in the girl</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0005" title="AdlerY , Zandman‐GoddardG , RavidM , AvidanB , ZemerD , EhrenfeldM , et al. Usefulness of colchicine in preventing recurrences of pericarditis. The American Journal of Cardiology1994;73(12):916‐7. [PUBMED: 8184826] ">Adler 1994</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 patients with recurrent pericarditis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/d)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No recurrences were noted during the 18 to 34 months of follow‐up. Drug withdrawal was 50% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0009" title="BrucatoA , BrambillaG , AdlerY , SpodickDH , CanesiB . Therapy for recurrent acute pericarditis: a rheumatological solution?. Clinical and Experimental Rheumatology2006;24(1):45‐50. [PUBMED: 16539818] ">Brucato 2006</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58 patients with recurrent pericarditis (34 men and 24 women) were followed up for an average of 8.1 years </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/day) for 18 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No further recurrence in 29/44 colchicine patients (65.9%). Drug withdrawal was 16%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0010" title="CacoubP , SbaiA , WechslerB , AmouraZ , GodeauP , PietteJC . [Efficacy of colchicine in recurrent acute idiopathic pericarditis] [Efficacite de la colchicine dans les pericardites aigues recidivantes idiopathiques]. Archives des Maladies du Coeur et des Vaisseaux2000;93(12):1511‐4. [PUBMED: 11211445] ">Cacoub 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13 patients (7 women and 6 men) with recurrent pericarditis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 to 2 mg/d) for 17 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No further recurrence in 10 (77%) patients</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0012" title="Grande IngelmoJM , Hernandez OseguedaM , Kallmeyer MartinC , Barroso LopezJL , Lopez BescosL . [Recurrent pericarditis: our experience with colchicine] [Pericarditis recurrente: nuestra experiencia con colchicina]. Revista Espanola de Cardiologia1995;48(11):765‐7. [PUBMED: 8532947] ">Grande 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 patients (age 24 to 64 years) with recurrent pericarditis. Followed up for 24 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/d) for 18 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no further recurrences of pericarditis during the follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0013" title="GuindoJ , Rodriguez de la SernaA , RamioJ , deMiguel DiazMA , SubiranaMT , Perez AyusoMJ , et al. Recurrent pericarditis. Relief with colchicine. Circulation1990;82(4):1117‐20. [PUBMED: 2205414] ">Guindo 1990</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9 patients (7 men and 2 women; age, 18 to 64 years) with recurrent pericarditis followed up for a mean of 24.3 months (10 to 54 month) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/d)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No recurrences of pericarditis were noted within the follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010652-bbs2-0038" title="Guindo , J , Adler , Y , Rodriguez De LaSerna , A , Genis , A.Bayes , Riesco , C.Martin , Finkelstein , Y , DeLuna , A.Bayes . Colchicine for recurrent pericarditis: influence of previous treatment with corticosteroids. European Heart Journal2002;23(Suppl):628. [http://eurekamag.com/research/034/601/034601978.php] ">Guindo 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 patients with recurrent pericarditis (36 men, 14 women; mean age 40.8 ± 18.7 years). Followed up for a median of 36 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 to 2 mg/day)<br/> <br/> (29 patients received steroids before colchicine) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 of 22 (27%) patients who received colchicine but no steroids had recurrences.</p> <p>14 of 29 (48%) patients who were treated with steroids before colchicine had recurrences</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010652-bbs2-0042" title="ImazioM , DemichelisB , CecchiE , GiuggiaM , FornoD , TrincheroR . Recurrent pericarditis: follow‐up of 55 cases. Circulation. 2002; Vol. 106 (Suppl II):323. ">Imazio 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55 patients with recurrent pericarditis. 10 patients treated with colchicine. The rest were treated with aspirin, or steroids, or both. Followed up for a mean of 36 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (loading dose of 2 mg then maintenance 1 mg/d)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Remission in 9 of 10 patients (90%) treated with colchicine compared to 33 of 48 (69%) with aspirin and 18 of 27 (67%) with steroids </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0014" title="ImazioM , DemichelisB , ParriniI , CecchiE , DemarieD , GhisioA , et al. Management, risk factors, and outcomes in recurrent pericarditis. The American Journal of Cardiology2005;96(5):736‐9. [PUBMED: 16125506] ">Imazio 2005b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 patients with recurrent pericarditis. Followed up for a mean of 72 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (loading dose of 2 mg then 1 mg/d maintenance) for 6 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Remission rate 32 of 35 patients (91.4%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0017" title="MillaireA , deGrooteP , DecoulxE , GoullardL , DuclouxG . Treatment of recurrent pericarditis with colchicine. European Heart Journal1994;15(1):120‐4. [PUBMED: 8174571] ">Millaire 1994</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19 patients (10 men, nine women, age 46 ± 7 years) who had recurrent pericarditis. Followed up for 32 to 44 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (loading dose of 3 mg then maintenance 1 mg/d)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 (74%) patients had no recurrences during a follow‐up period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0016" title="Rodriguez de la SernaA , Guindo SoldevilaJ , Marti ClaramuntV , Bayes de LunaA . Colchicine for recurrent pericarditis. Lancet1987; Vol. 2, issue 8574:1517. [PUBMED: 2892065] ">la Serna 1987</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 patients with recurrent pericarditis. Followed up for 15 to 35 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/d) for 2 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No relapses throughout the follow‐up period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is useful in the prevention of recurrence of acute pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0062" title="SeferovicPM , RisticAD , MaksimovicR , SimeunovicD , TrifunovicD , OstojicM . Chronic versus recurrent pericarditis: should we give colchicine to everybody?. European Heart Journal2002;23:354. ">Seferovic 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17 into two groups. Group 1 had 7 patients with idiopathic chronic non‐recurring pericarditis. Group 2 had 10 patients with idiopathic recurring pericarditis </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (loading dose of 2 mg for one week then a maintenance dose of 1.5 mg/d) for 5 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disappearance of the pericardial effusion in 60% of patients from group 2 compared to 14% in group 1. Relief of symptoms in 80% of group 1 and 28% of group 2 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is useful in treating the symptoms of recurrent pericarditis.<br/> However, recurrences were not reported </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0018" title="RaatikkaM , PelkonenPM , KarjalainenJ , JokinenEV . Recurrent pericarditis in children and adolescents: report of 15 cases. Journal of the American College of Cardiology2003;42(4):759‐64. [PUBMED: 12932616] ">Raatikka 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 children (aged 7 to 17 years) with recurrent pericarditis. Followed up for 4 to 16 years (mean 8 years) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (0.5 to 2 mg/d)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All patients had further recurrences of pericarditis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine did not prevent pericarditis relapses in children</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0048" title="JurkoA , PokornyD , FarskaZ , SparcovaA . Colchicine in atypical forms of pericarditis in children. Advances in Heart failure; Proceedings of the 8th World Congress on Heart Failure ‐ Mechanisms and Management; 2002 July 13‐16; Washington, DC. Bologna: Medimond Medical, 2002:327‐34. ">Jurko 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two case reports</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 children with a severe form of idiopathic recurrent pericarditis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No further relapses occurred during a period of 12 months in the first case and 9 months in the second case </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is useful in the prevention of recurrence of pericarditis in children</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0019" title="YazigiA , Abou‐CharafLC . Colchicine for recurrent pericarditis in children. Acta Paediatrica1998;87(5):603‐4. [PUBMED: 9641750] ">Yazigi 1998</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 children with recurrent pericarditis. Followed up for 17 to 24 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (0.5 to 1.5 mg loading dose then 0.25 to 0.5 mg/d maintenance) for 6 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No relapses throughout the follow‐up period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is useful in the prevention of recurrence of pericarditis in children</p> </td> </tr> </tbody> </table> </div> <p>It was not possible to perform a subgroup analysis on the dose used as all trials used the same dose of colchicine (1 mg/day). A review of observational studies (<a href="#CD010652-tbl-0007">Table 2</a>) showed that the most frequent dose used is 1 mg/d (10 of 15 studies). The rest of the reports used doses varying from 0.25 to 2 mg/d with or without a loading dose. </p> </section> <section id="CD010652-sec-0098"> <h4 class="title">Sensitivity analysis</h4> <p>Due to the limited number of studies, it was not possible to conduct a sensitivity analysis for studies that we judged to be at high risk of bias across at least one domain. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010652-sec-0099" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010652-sec-0099"></div> <section id="CD010652-sec-0100"> <h3 class="title" id="CD010652-sec-0100">Summary of main results</h3> <p>The main results of the review compare the recurrence of pericarditis in people taking colchicine in addition to a NSAID such as ibuprofen, aspirin or indomethacin to the recurrence of pericarditis in people taking a NSAID alone. We included four trials with a total of 564 adult participants in this review. Two studies (<a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>; <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>) included 204 participants with recurrent pericarditis and showed that colchicine is effective in preventing further recurrences. The evidence shows that, the risk of pericarditis recurrence in people with recurrent pericarditis, who are taking colchicine, is 37% of the risk of recurrence in people not taking colchicine over a period of 18 months. Thus, the average reduction in recurrence of pericarditis with colchicine compared to NSAIDs alone is 63% over a period of 18 months. The risk of having a recurrent episode of pericarditis at 6, 12 and 18 months is reduced by 72%, 64% and 63% respectively. It is expected that at 18 months, one pericarditis recurrence can be avoided for every four people receiving colchicine with NSAIDs rather than NSAIDs alone. </p> <p>Two studies (<a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>; <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>) included 360 people with acute pericarditis and assessed the recurrence of pericarditis. The evidence shows that the average reduction in recurrence of pericarditis with colchicine compared to NSAIDs alone is 60% over a period of 18 months. The risk of having a recurrent episode of pericarditis at 6, 12 or 18 months is reduced by 64%, 60% and 59% respectively. </p> <p>The primary outcomes are summarised in the following table.</p> <p> <div class="table" id="CD010652-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk of relapse without colchicine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk of relapse with colchicine over 18 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. patients with<br/> adverse effects<br/> for 100 treated</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acute pericarditis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20% to 30% (<a href="./references#CD010652-bbs2-0036" title="FowlerNO . Recurrent pericarditis. Cardiology Clinics1990;8(4):621‐6. ">Fowler 1990</a>; <a href="./references#CD010652-bbs2-0006" title="AdlerY , FinkelsteinY , GuindoJ , Rodriguez de la SernaA , ShoenfeldY , Bayes‐GenisA , et al. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation1998;97(21):2183‐5. [PUBMED: 9626180] ">Adler 1998</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8% to 15% (<a href="./references#CD010652-fig-0005" title="">Analysis 1.2</a>, <a href="./references#CD010652-fig-0013" title="">Analysis 4.3</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Recurrent pericarditis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40% to 50% (<a href="./references#CD010652-bbs2-0064" title="Soler‐SolerJ , Sagrista‐SauledaJ , Permanyer‐MiraldaG . Relapsing pericarditis. Heart2004;90(11):1364‐8. ">Soler‐Soler 2004</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15% to 20% (<a href="./references#CD010652-fig-0004" title="">Analysis 1.1</a>, <a href="./references#CD010652-fig-0010" title="">Analysis 3.3</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> </tbody> </table> </div> </p> <p>Adverse events were reported in all studies. Combining the results of all 564 participants showed a similar adverse events rate in both the intervention and control group. All adverse events were related to the gastrointestinal system. The adverse effects in the colchicine group were almost twice more likely to be the cause of stopping treatment than in the control group. </p> <p>The review showed that colchicine is effective in reducing the symptoms of pericarditis. The combined data of all studies shows that symptoms of the pericarditis episode are reduced by up to 60% in the colchicine group compared to the control group. </p> <p>We used GradePro to create a summary of the findings and quality of the evidence (<a href="./full#CD010652-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD010652-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD010652-tbl-0003">summary of findings Table 3</a>; <a href="./full#CD010652-tbl-0004">summary of findings Table 4</a>; <a href="./full#CD010652-tbl-0005">summary of findings Table 5</a>). </p> </section> <section id="CD010652-sec-0101"> <h3 class="title" id="CD010652-sec-0101">Overall completeness and applicability of evidence</h3> <p>The two combined studies for acute pericarditis (<a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>; <a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>) and for recurrent pericarditis (<a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>; <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>) were homogenous in methodology, patients baseline characteristics, intervention duration and dose and outcomes. This makes the combined result a robust estimate of effect, however it might be limited as to how it can be generalised to different populations (<a href="./references#CD010652-bbs2-0027" title="BermanN , ParkerR . Meta‐analysis: neither quick nor easy. BMC Medical Research Methodology2002;2(1):10. ">Berman 2002</a>). </p> <p>All participants in the included trials were Italians with a mean age of 47 to 57 years. Consequently, the evidence has limited applicability to children, elderly adults or people from an ethnicity other than European.<br/> <br/> Patients with several recurrences were not studied. Consequently, it is possible that the studies represent a population with a lower risk of recurrence and better response to therapy. The results of this review, therefore might not apply to patients with resistant multiple recurrences. Pregnant and lactating women or fertile women not protected by a contraceptive method are also not represented by the studies. In addition, people were excluded from the trials if they were receiving or had previously received colchicine for any indication. Therefore, results might not be applicable to patients taking colchicine for any other medical condition such as gout. People with abnormal liver function were also excluded, although this might have been because of acute infections or medications (<a href="./references#CD010652-bbs2-0022" title="AdlerY , SpodickDH , ShabetaiR , BrucatoA . Can colchicine prevent recurrence of new‐onset acute pericarditis?. Nature Clinical Practice. Cardiovascular Medicine2006;3(2):78‐9. ">Adler 2006</a>). </p> <p>The colchicine therapy duration of three months for acute pericarditis and six months for recurrent pericarditis is debatable. It was not possible to do a subgroup analysis for different doses or therapy durations. In order to identify different regimes of duration and dose of treatment, we systematically identified and reviewed non‐RCT publications. This search retrieved 15 reports (<a href="#CD010652-tbl-0007">Table 2</a>). The duration of therapy ranged from one or two months to 18 months. The suggested duration of therapy in this review might not apply to all patients in a clinical setting and different durations might be needed for different patients. </p> <p>The review of all non‐randomised trials (<a href="#CD010652-tbl-0007">Table 2</a>) shows that a loading dose has not always been used and that there is no universal agreement on the dosage of the loading dose which ranged from 1 mg to 3 mg. This review could not assess the importance of the loading dose, as a subgroup analysis or comparison with a trial that has not used a loading dose was not possible. </p> </section> <section id="CD010652-sec-0102"> <h3 class="title" id="CD010652-sec-0102">Quality of the evidence</h3> <p>All included studies are RCTs. We judged the outcomes, studying time to recurrence and recurrence rates, to be of a moderate methodological quality using the GRADE approach (<a href="./references#CD010652-bbs2-0037" title="BrozekJ , OxmanA , SchünemannH . GRADEpro. Version 3.2. The GRADE Working Group, 2008. ">GRADEpro 2008</a>). </p> <p>All three included studies stated that they were randomised trials but only <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> adequately reported the randomising method and the allocation sequence generation. </p> <p>The <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a> trial had a double‐blind design. Although duration of therapies in the intervention and control group varied largely, which might have undermined the blinding of participants, outcomes were determined by blinded assessors and objective outcome measures. Two studies, <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>, were open‐label design without blinding of the participants or researchers, however both had blinded outcome assessors and an external data analysis committee masked to intervention allocation. </p> <p>The comparator in all trials was either aspirin (800 mg) or prednisolone in <a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a> and <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a> or as an additional alternative, ibuprofen in <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>. However in clinical practice, stronger NSAIDs such as ibuprofen, indomethacin or higher aspirin doses (1000 to 2000 mg/d) tend to be used. This might have positively affected the apparent benefit of colchicine.<br/> <br/> All included studies followed an intention‐to‐treat (ITT) approach and every randomised participant was followed up and analysed. </p> <p>The quality of evidence for symptom relief during the pericarditis episode is of low quality. The time point chosen to assess the symptoms was subjectively chosen and symptoms were not reported over a range of time, suggesting a high risk of selective reporting. Additionaly, it is not clear which symptoms were relieved or to what extend the symptoms were reduced. No description was made on how the symptoms were assessed or measured. Complete study protocols were not available to make judgements regarding the risk of selective reporting. </p> </section> <section id="CD010652-sec-0103"> <h3 class="title" id="CD010652-sec-0103">Potential biases in the review process</h3> <p>The review was conducted according to the previously published protocol. Attempts have been made to minimise review bias by having two authors independently perform the literature search, study selection, data extraction and risk of bias assessment. Unfortunately, we were unable to obtain study protocols of the included studies from the study authors. We were also unable to use funnel plots to determine if there was any publication bias as we only found four studies. It is unlikely that there are any published randomised trials that have been overlooked in this review. </p> </section> <section id="CD010652-sec-0104"> <h3 class="title" id="CD010652-sec-0104">Agreements and disagreements with other studies or reviews</h3> <p>The authors of the included trials (<a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. ">Imazio 2005</a>; <a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. ">Imazio 2005a</a>; <a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. ">Imazio 2011</a>) performed a systematic review of their studies, published in the <i>Heart</i> journal (<a href="./references#CD010652-bbs2-0047" title="ImazioM , BrucatoA , FornoD , FerroS , BelliR , TrincheroR , et al. Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta‐analysis. Heart2012;98(14):1078‐82. ">Imazio 2012</a>). The main contrast with this review is that they analysed all pericardial disease (acute pericarditis, recurrent pericarditis and postpericardial syndrome) in one meta‐analysis. Our approach was to exclude postpericardial syndrome due to the different aetiology and pathophysiology than that of acute or recurrent pericarditis. In addition, we decided not to pool the trials of acute and recurrent pericarditis together as there are significant differences in the baseline risk for further recurrence of pericarditis. In addition, our review included an independent risk of bias assessment involving authors not participating in the initial trial. This review includes the results of an additional study (<a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. ">Imazio 2013</a>) not included in the <i>Heart</i> journal review <a href="./references#CD010652-bbs2-0047" title="ImazioM , BrucatoA , FornoD , FerroS , BelliR , TrincheroR , et al. Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta‐analysis. Heart2012;98(14):1078‐82. ">Imazio 2012</a>. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010652-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010652-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010652-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010652-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Time to recurrence, Outcome 1 Time to recurrence in people with recurrent pericarditis." data-id="CD010652-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Time to recurrence, Outcome 1 Time to recurrence in people with recurrent pericarditis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Time to recurrence, Outcome 2 Time to recurrence in people with acute pericarditis." data-id="CD010652-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Time to recurrence, Outcome 2 Time to recurrence in people with acute pericarditis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Adverse effects of colchicine, Outcome 1 Total adverse effects." data-id="CD010652-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Adverse effects of colchicine, Outcome 1 Total adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Adverse effects of colchicine, Outcome 2 Adverse effects necessitating stop of therapy." data-id="CD010652-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Adverse effects of colchicine, Outcome 2 Adverse effects necessitating stop of therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Recurrence rate in people with recurrent pericarditis, Outcome 1 6 months." data-id="CD010652-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Recurrence rate in people with recurrent pericarditis, Outcome 1 6 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Recurrence rate in people with recurrent pericarditis, Outcome 2 12 months." data-id="CD010652-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Recurrence rate in people with recurrent pericarditis, Outcome 2 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Recurrence rate in people with recurrent pericarditis, Outcome 3 18 months." data-id="CD010652-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Recurrence rate in people with recurrent pericarditis, Outcome 3 18 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Recurrence rate in people with acute pericarditis, Outcome 1 6 months." data-id="CD010652-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Recurrence rate in people with acute pericarditis, Outcome 1 6 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Recurrence rate in people with acute pericarditis, Outcome 2 12 months." data-id="CD010652-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Recurrence rate in people with acute pericarditis, Outcome 2 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Recurrence rate in people with acute pericarditis, Outcome 3 18 months." data-id="CD010652-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Recurrence rate in people with acute pericarditis, Outcome 3 18 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010652-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/urn:x-wiley:14651858:media:CD010652:CD010652-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_t/tCD010652-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Symptom relief, Outcome 1 Symptom relief at 72 hours." data-id="CD010652-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Symptom relief, Outcome 1 Symptom relief at 72 hours.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/media/CDSR/CD010652/image_n/nCD010652-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010652-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Time to recurrence of pericarditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Time to recurrence of pericarditis</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recurrent pericarditis</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Intervention: colchicine with NSAID; Comparison: NSAID alone<br/> Follow‐up: median 18 months<br/> Setting: multicentre secondary care </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.37</b> <br/> (0.24 to 0.58) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Acute pericarditis</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers) </p> <p>Intervention: colchicine with NSAID; Comparison: NSAID alone</p> <p>Follow‐up: median 18 months<br/> Setting: multicentre secondary care </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.40</b> <br/> (0.27 to 0.61) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>360<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>ECG</b> : electrocardiography; <b>HR:</b> Hazard ratio; <b>NSAID</b>: non‐steroidal anti‐inflammatory drug </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> High risk of bias in blinding domain. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Time to recurrence of pericarditis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010652-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Adverse effects of colchicine</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Adverse effects of colchicine for pericarditis</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Colchicine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Total adverse effects</b> <br/> Patient reported<br/> Follow‐up: median 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.26</b> <br/> (0.75 to 2.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>564<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕</p> <p><b>low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>103 per 1000</b> <br/> (61 to 173) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>69 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>87 per 1000</b> <br/> (52 to 146) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse effects necessitating stop of therapy</b> <br/> Patient reported<br/> Follow‐up: median 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.87</b> <br/> (1.02 to 3.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>564<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>93 per 1000</b> <br/> (51 to 169) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>62 per 1000</b> <br/> (34 to 113) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> P value &gt; 0.05 (imprecise).<br/> <sup>2</sup> High risk of bias in blinding domain. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Adverse effects of colchicine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010652-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Recurrences in patients with recurrent pericarditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Recurrences in patients with recurrent pericarditis</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Colchicine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>6 months</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Follow‐up: mean 6 months </p> <p>Intervention: colchicine with NSAID<br/> Comparison: NSAID alone<br/> Setting: multicentre secondary care </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.28</b> <br/> (0.17 to 0.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>204<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>1,2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>490 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>137 per 1000</b> <br/> (83 to 230) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>481 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>135 per 1000</b> <br/> (82 to 226) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>12 months</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Follow‐up: median 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.36</b> <br/> (0.23 to 0.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>204<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>1,2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>520 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>187 per 1000</b> <br/> (120 to 291) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>510 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>184 per 1000</b> <br/> (117 to 286) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>18 months</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Follow‐up: median 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.38</b> <br/> (0.25 to 0.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>204<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>1,2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>539 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>205 per 1000</b> <br/> (135 to 313) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>533 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>203 per 1000</b> <br/> (133 to 309) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> High risk of bias in blinding domain.<br/> <sup>2</sup> Low precision (small sample size and small number of events). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Recurrences in patients with recurrent pericarditis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010652-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Recurrence rate in patients with acute pericarditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Recurrence rate in patients with acute pericarditis</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Colchcine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>6 months</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Follow‐up: mean 6 months<br/> Intervention: colchicine with NSAID </p> <p>Comparison: NSAID alone<br/> Setting: multicentre secondary care </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.36</b> <br/> (0.23 to 0.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>360<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>306 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>110 per 1000</b> <br/> (70 to 177) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>292 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>105 per 1000</b> <br/> (67 to 169) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>12 months</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Follow‐up: median 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.4</b> <br/> (0.26 to 0.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>360<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>333 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>133 per 1000</b> <br/> (87 to 203) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>321 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>128 per 1000</b> <br/> (83 to 196) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>18 months</b> <br/> Chest pain + (ECG changes +/‐ echocardiographic changes +/‐ raised inflammatory markers)<br/> Follow‐up: median 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.41</b> <br/> (0.28 to 0.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>360<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕<br/> <b>moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>367 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000</b> <br/> (103 to 224) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>358 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>147 per 1000</b> <br/> (100 to 218) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> High risk of bias in blinding domain. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Recurrence rate in patients with acute pericarditis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010652-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Symptom relief for pericarditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Symptom relief for pericarditis</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Colchcine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Symptom relief at 72 hours</b> <br/> Patient reported<br/> Follow‐up: median 7 days<br/> Intervention: colchicine with NSAID </p> <p>Comparison: NSAID alone<br/> Setting: multi centre secondary care </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.40</b> <br/> (1.26 to 1.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>564<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕<br/> <b>low</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>592 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>829 per 1000</b> <br/> (746 to 924) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>617 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>864 per 1000</b> <br/> (777 to 963) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Two open‐label studies.<br/> <sup>2</sup> High risk of bias in selective reporting domain. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Symptom relief for pericarditis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010652-tbl-0006"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Baseline characteristics</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Characteristics</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0001" title="ImazioM , BobbioM , CecchiE , DemarieD , DemichelisB , PomariF , et al. COPE: Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation2005;112(13):2012‐6. ImazioM , DemichelisB , CecchiE , GaschinoG , DemarieD , GhisioA , et al. Is colchicine the initial mode of treatment for acute pericarditis?. European Heart Journal2003;24:250. "><b>Imazio 2005</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0002" title="ImazioM , BobbioM , CecchiE , DemarieD , PomariF , MorattiM , et al. CORE: Colchicine as first‐choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Archives of Internal Medicine2005;165(17):1987‐91. "><b>Imazio 2005a</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0003" title="ImazioM , CecchiE , IernaS , TrincheroR , CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP‐2 trials‐two randomized placebo‐controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. Journal of Cardiovascular Medicine2007;8(10):830‐4. "><b>Imazio 2011</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0004" title="ImazioM , BrucatoA , CeminR , FerruaS , MaggioliniS , BeqarajF , et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. New England Journal of Medicine2013;369(16):1522‐8. "><b>Imazio 2013</b> </a> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Colchicine</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Colchicine</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Colchicine</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Colchicine</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56.5 ± 18.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57.2 ± 19.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56.4 ± 16.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51.2 ±16.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47.9 ± 15.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47.3 ± 14.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.5 ± 16.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50.7 ± 17.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Male</p> <p>Female</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46.7%</p> <p>53.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43.3%</p> <p>56.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> <p>62%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31%</p> <p>69%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43%</p> <p>57%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48%</p> <p>52%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.2%</p> <p>40.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61.7%</p> <p>38.3%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Region</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pericarditic chest pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.2%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pericardial rub</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.7%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ECG changes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n.a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n.a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.7%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pericardial effusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68.3%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiac tamponade</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n.a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n.a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Idiopathic pericarditis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.5%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Autoimmune pericarditis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.3%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroid use on index attack</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n.a</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Baseline characteristics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010652-tbl-0007"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Review of observational studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Author and date</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Study type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Results</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Conclusion</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0006" title="AdlerY , FinkelsteinY , GuindoJ , Rodriguez de la SernaA , ShoenfeldY , Bayes‐GenisA , et al. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation1998;97(21):2183‐5. [PUBMED: 9626180] ">Adler 1998</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 patients (36 men and 15 women; mean ± SD age, 40.8 ± 18.7 years) with recurrent pericarditis followed up for &lt; or = 10 years </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/day)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31 patients (60.7%) remained recurrence‐free.</p> <p>Drug withdrawal in 39 (76%) patients</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0007" title="AdlerY , GuindoJ , FinkelsteinY , KhouriA , AssaliA , Bayes‐GenisA , et al. Colchicine for large pericardial effusion. Clinical Cardiology1998;21(2):143‐4. [PUBMED: 9491960] ">Adler 1998a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two case reports</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a 26‐year‐old male and a 2‐year‐old girl with idiopathic pericarditis and pericardial effusion </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/day) for 1 month in the man and 6 months in the child</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No recurrences in 24 months follow‐up in the man and 6 months follow‐up in the girl</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0005" title="AdlerY , Zandman‐GoddardG , RavidM , AvidanB , ZemerD , EhrenfeldM , et al. Usefulness of colchicine in preventing recurrences of pericarditis. The American Journal of Cardiology1994;73(12):916‐7. [PUBMED: 8184826] ">Adler 1994</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 patients with recurrent pericarditis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/d)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No recurrences were noted during the 18 to 34 months of follow‐up. Drug withdrawal was 50% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0009" title="BrucatoA , BrambillaG , AdlerY , SpodickDH , CanesiB . Therapy for recurrent acute pericarditis: a rheumatological solution?. Clinical and Experimental Rheumatology2006;24(1):45‐50. [PUBMED: 16539818] ">Brucato 2006</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58 patients with recurrent pericarditis (34 men and 24 women) were followed up for an average of 8.1 years </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/day) for 18 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No further recurrence in 29/44 colchicine patients (65.9%). Drug withdrawal was 16%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0010" title="CacoubP , SbaiA , WechslerB , AmouraZ , GodeauP , PietteJC . [Efficacy of colchicine in recurrent acute idiopathic pericarditis] [Efficacite de la colchicine dans les pericardites aigues recidivantes idiopathiques]. Archives des Maladies du Coeur et des Vaisseaux2000;93(12):1511‐4. [PUBMED: 11211445] ">Cacoub 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13 patients (7 women and 6 men) with recurrent pericarditis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 to 2 mg/d) for 17 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No further recurrence in 10 (77%) patients</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0012" title="Grande IngelmoJM , Hernandez OseguedaM , Kallmeyer MartinC , Barroso LopezJL , Lopez BescosL . [Recurrent pericarditis: our experience with colchicine] [Pericarditis recurrente: nuestra experiencia con colchicina]. Revista Espanola de Cardiologia1995;48(11):765‐7. [PUBMED: 8532947] ">Grande 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 patients (age 24 to 64 years) with recurrent pericarditis. Followed up for 24 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/d) for 18 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no further recurrences of pericarditis during the follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0013" title="GuindoJ , Rodriguez de la SernaA , RamioJ , deMiguel DiazMA , SubiranaMT , Perez AyusoMJ , et al. Recurrent pericarditis. Relief with colchicine. Circulation1990;82(4):1117‐20. [PUBMED: 2205414] ">Guindo 1990</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9 patients (7 men and 2 women; age, 18 to 64 years) with recurrent pericarditis followed up for a mean of 24.3 months (10 to 54 month) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/d)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No recurrences of pericarditis were noted within the follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010652-bbs2-0038" title="Guindo , J , Adler , Y , Rodriguez De LaSerna , A , Genis , A.Bayes , Riesco , C.Martin , Finkelstein , Y , DeLuna , A.Bayes . Colchicine for recurrent pericarditis: influence of previous treatment with corticosteroids. European Heart Journal2002;23(Suppl):628. [http://eurekamag.com/research/034/601/034601978.php] ">Guindo 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 patients with recurrent pericarditis (36 men, 14 women; mean age 40.8 ± 18.7 years). Followed up for a median of 36 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 to 2 mg/day)<br/> <br/> (29 patients received steroids before colchicine) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 of 22 (27%) patients who received colchicine but no steroids had recurrences.</p> <p>14 of 29 (48%) patients who were treated with steroids before colchicine had recurrences</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010652-bbs2-0042" title="ImazioM , DemichelisB , CecchiE , GiuggiaM , FornoD , TrincheroR . Recurrent pericarditis: follow‐up of 55 cases. Circulation. 2002; Vol. 106 (Suppl II):323. ">Imazio 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55 patients with recurrent pericarditis. 10 patients treated with colchicine. The rest were treated with aspirin, or steroids, or both. Followed up for a mean of 36 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (loading dose of 2 mg then maintenance 1 mg/d)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Remission in 9 of 10 patients (90%) treated with colchicine compared to 33 of 48 (69%) with aspirin and 18 of 27 (67%) with steroids </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0014" title="ImazioM , DemichelisB , ParriniI , CecchiE , DemarieD , GhisioA , et al. Management, risk factors, and outcomes in recurrent pericarditis. The American Journal of Cardiology2005;96(5):736‐9. [PUBMED: 16125506] ">Imazio 2005b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 patients with recurrent pericarditis. Followed up for a mean of 72 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (loading dose of 2 mg then 1 mg/d maintenance) for 6 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Remission rate 32 of 35 patients (91.4%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0017" title="MillaireA , deGrooteP , DecoulxE , GoullardL , DuclouxG . Treatment of recurrent pericarditis with colchicine. European Heart Journal1994;15(1):120‐4. [PUBMED: 8174571] ">Millaire 1994</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19 patients (10 men, nine women, age 46 ± 7 years) who had recurrent pericarditis. Followed up for 32 to 44 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (loading dose of 3 mg then maintenance 1 mg/d)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 (74%) patients had no recurrences during a follow‐up period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is effective in the treatment of recurrent pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0016" title="Rodriguez de la SernaA , Guindo SoldevilaJ , Marti ClaramuntV , Bayes de LunaA . Colchicine for recurrent pericarditis. Lancet1987; Vol. 2, issue 8574:1517. [PUBMED: 2892065] ">la Serna 1987</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 patients with recurrent pericarditis. Followed up for 15 to 35 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (1 mg/d) for 2 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No relapses throughout the follow‐up period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is useful in the prevention of recurrence of acute pericarditis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0062" title="SeferovicPM , RisticAD , MaksimovicR , SimeunovicD , TrifunovicD , OstojicM . Chronic versus recurrent pericarditis: should we give colchicine to everybody?. European Heart Journal2002;23:354. ">Seferovic 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17 into two groups. Group 1 had 7 patients with idiopathic chronic non‐recurring pericarditis. Group 2 had 10 patients with idiopathic recurring pericarditis </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (loading dose of 2 mg for one week then a maintenance dose of 1.5 mg/d) for 5 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disappearance of the pericardial effusion in 60% of patients from group 2 compared to 14% in group 1. Relief of symptoms in 80% of group 1 and 28% of group 2 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is useful in treating the symptoms of recurrent pericarditis.<br/> However, recurrences were not reported </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0018" title="RaatikkaM , PelkonenPM , KarjalainenJ , JokinenEV . Recurrent pericarditis in children and adolescents: report of 15 cases. Journal of the American College of Cardiology2003;42(4):759‐64. [PUBMED: 12932616] ">Raatikka 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 children (aged 7 to 17 years) with recurrent pericarditis. Followed up for 4 to 16 years (mean 8 years) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (0.5 to 2 mg/d)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All patients had further recurrences of pericarditis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine did not prevent pericarditis relapses in children</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0048" title="JurkoA , PokornyD , FarskaZ , SparcovaA . Colchicine in atypical forms of pericarditis in children. Advances in Heart failure; Proceedings of the 8th World Congress on Heart Failure ‐ Mechanisms and Management; 2002 July 13‐16; Washington, DC. Bologna: Medimond Medical, 2002:327‐34. ">Jurko 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two case reports</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 children with a severe form of idiopathic recurrent pericarditis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No further relapses occurred during a period of 12 months in the first case and 9 months in the second case </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is useful in the prevention of recurrence of pericarditis in children</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010652-bbs2-0019" title="YazigiA , Abou‐CharafLC . Colchicine for recurrent pericarditis in children. Acta Paediatrica1998;87(5):603‐4. [PUBMED: 9641750] ">Yazigi 1998</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 children with recurrent pericarditis. Followed up for 17 to 24 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine (0.5 to 1.5 mg loading dose then 0.25 to 0.5 mg/d maintenance) for 6 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No relapses throughout the follow‐up period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colchicine is useful in the prevention of recurrence of pericarditis in children</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Review of observational studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/full#CD010652-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010652-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Time to recurrence</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Time to recurrence in people with recurrent pericarditis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.24, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Time to recurrence in people with acute pericarditis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.27, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Time to recurrence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010652-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Adverse effects of colchicine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>564</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.75, 2.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Adverse effects necessitating stop of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>564</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [1.02, 3.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Adverse effects of colchicine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010652-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Recurrence rate in people with recurrent pericarditis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.17, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.23, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 18 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.25, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Recurrence rate in people with recurrent pericarditis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010652-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Recurrence rate in people with acute pericarditis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.23, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.4 [0.26, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 18 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.28, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Recurrence rate in people with acute pericarditis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010652-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Symptom relief</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Symptom relief at 72 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>564</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [1.26, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Symptom relief</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010652.pub2/references#CD010652-tbl-0012">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010652.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010652-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010652-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010652-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD010652-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ru#CD010652-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010652\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010652\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010652\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010652\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010652\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UiM8QuvV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010652.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010652.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010652.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010652.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010652.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718912110"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010652.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718912114"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010652.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ddbeb3c561be5',t:'MTc0MDcxODkxMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 